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Abbreviations 
1KDCI, 1-keto-D-chiro-inositol 
5DG, 5-deoxy-D-glucuronic acid 
Abeta, beta-amyloid peptide 
AD, Alzheimer’s disease 
DCI, D-chiro-inositol 
DKG, 2-deoxy-5-keto-D-gluconic acid 
DKGP, DKG 6-phosphate 
HPLC, high performance liquid chromatography 
IPTG, isopropyl β-D-1-thiogalactopyranoside 
LB, Luria–Bertani 
MI, myo-inositol 
MSA, malonic semialdehyde 
PrpsO, rpsO promoter 
Pspac, spac promoter 
SI, scyllo-inositol 
SIS, scyllo-inosose 
THcHDO, 3D-(3,4/5)-trihydroxycyclohexane-1,2-dione 
X-gal, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside. 
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Chapter 1 
General introduction 
 
Inositols 
Inositol (1,2,3,4,5,6-cyclohexanehexol) stands for a group of compounds with 
formula C6H12O6, namely a six-fold alcohol of cyclohexane. Inositol is a sugar alcohol that 
tastes at half the sweetness of sucrose. Epimerizing the six hydroxyl groups, inositol can be 
existing in nine possible stereoisomers. 
 
Fig. 1-1. Structure of three inositol stereoisomers. (a) myo-Inositol (MI) is the most of abundant 
inositol in nature. (b and c) scyllo-inositol (SI) and D-chiro-inositol (DCI), that are the products 
epimerizing the C2 and C1 hydroxyl groups of MI, respectively. 
 
myo-Inositol (MI) (Fig. 1-1a) is the most prominent form of inositol, widely 
occurring in nature. MI is important component of the structural lipids phosphatidylinositol 
and its various phosphates, the phosphatidylinositol phosphatelipids. Furthermore, MI is 
known for its indispensable role as the moiety of a number of secondary messengers in 
eukaryotic cells, including the various its phosphorylated forms. MI and its phosphates and 
associated lipids are often seen in foods. In particular, phytate (hexaphosphate of MI, or its 
salts) is found in plant, which especially serves as phosphate storage in seeds. Phytates occur 
also in cereals, nuts, and beans with high bran content. When present as phytate, MI is not 
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directly bioavailable to humans, because it is non-digestible, but it can be enjoyable only after 
some particular food preparation techniques that break it down to free phosphates. MI was 
once known as one of the vitamin B. However, it was shown to be produced in the human 
body from glucose, and now it is not regarded as an essential nutrient. 
The other inositol stereoisomers are rare in nature, but some of them, especially the 
scyllo-inositol (SI) (Fig. 1-1b) and D-chiro-inositol (DCI) (Fig. 1-1c), are reported to have 
specific physiological functions and sometimes regarded as drug candidates as described in 
the next section. 
 
The physiological functions of inositol 
As described above, MI presents in animal and plant cells in free form as well as 
some bound forms in phospholipids or inositol phosphate derivatives, which play important 
roles biologically. MI is essential and important of cell function including cell growth and 
survival, development and function of peripheral nerves, osteogenesis, and polycystic ovary 
syndrome (Ciotta et al., 2011; Dai et al., 2011) 
SI, C-2 epimer of MI (Fig. 1-1b), exists much more rarely in nature, but is sometime 
found in several organisms, including barley seeds (Kinnard et al., 1995), Terahymena vorax 
(Riggs et al., 2007), and early stage of flower bud in chrysanthemum (Ichimura et al., 2000). 
In mammals, some SI exists in the kidney and brain (Sherman et al., 1968). Intriguingly, it 
was shown that SI can directly interact with beta-amyloid peptide, which is the hallmark of 
Alzheimer’s patients to cause damage of hippocampal synaptic plasticity and memory 
deficits, to inhibit its aggregation and block the development of Alzheimer’s disease 
(McLaurin et al., 2000). 
DCI, C-1 epimer of MI (Fig. 1-1c), can be found in some plants, such as Cucurbita 
ficifolia (Xia & Wang, 2006), and in human urine (Kennington et al., 1990) and tissue (Niwa 
et al., 1983), and its rich source form in nature is D-pinitol (3-O-methyl-DCI), which often 
exists in pinewood and legumes such as soybean (Taira et al., 1990). It is reported that DCI 
and D-pinitol are beneficial for patients with hyperglycemia (Larner, 2002) and polycystic 
ovary syndrome (Iuorno et al., 2002). It was also shown that part of D-pinitol absorbed in 
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human can be converted into DCI (Davis et al., 2000). 
 
Inositol Metabolism in Bacillus subtilis 
In bacteria, usually inositol does not have any specific biological functions but serves 
as one of the carbon sources. A number of microorganisms, including Aerobacter aerogenes 
(Berman & Magasanik, 1966), Bacillus subtilis (Fujita et al., 1991), Corynebacterium 
glutamicum (Krings et al., 2006), Cryptococcus melibiosum (Vidal-Leiria & van Uden, 1973), 
Geobacillus kaustophilus (Yoshida et al., 2012), Lactobacillus casei (Yebra et al., 2007), 
Rhizobium leguminosarum (Poole et al., 1994), Sinorhizobium fredii (Jiang et al., 2001), and 
Sinorhizobium meliloti (Galbraith et al., 1998), possess a specific inositol degradation 
pathway. In particular, B. subtilis is one of the most studied Gram-positive bacteria and its 
inositol metabolic pathway was fully elucidated (Fig. 1-2).  
In B. subtilis, at least three transcriptional units of iolABCDEFGHIJ, iolRS, and iolT 
were shown to be required for its MI metabolism (Yoshida et al., 2008). The 
iolABCDEFGHIJ operon encodes the multiple enzymes for the MI metabolic pathway, iolR 
does the transcriptional repressor, and iolT the major MI transporter. The first step of the 
metabolic pathway, MI is converted to scyllo-inosose (SIS; also called 2-keto-myo-inositol) 
by IolG (Fujita et al., 1991). SIS is dehydrated to 3D-(3,4/5)-trihydroxycyclohexane-1,2-
dione (THcHDO) by IolE (Yoshida et al., 2004) and THcHDO is converted to 5-deoxy-D-
glucuronic acid (5DG) by IolD. 5DG is isomerized to 2-deoxy-5-keto-D-gluconic acid (DKG) 
by IolB and DKG is phosphorylated to 2-deoxy-5-keto-D-gluconic acid 6-phosphate (DKGP) 
by IolC (Yoshida et al., 2008). The DKGP is the intermediated inducer by antagonizing of 
IolR (Yoshida et al., 1999). The last step, IolJ catalses the cleavage of DKPG to 
dihydroxyacetone phosphate and malonic semialdehyde (MSA) (Yoshida et al., 2008). MSA 
is converted to acetyl-CoA and CO2 by IolA (Stines-Chaumeil et al., 2006).  
For degradation of DCI, IolG can also react on DCI to 1-keto-D-chiro-inositol 
(1KDCI) and 1KDCI is converted to SIS by IolI (Yoshida et al., 2006). For SI, the two 
additional inositol dehydrogenases, IolX (also called YisS) and IolW (YvaA), act on SI via 
NAD
+
- and NADP
+
-dependent reactions, respectively (Morinaga et al., 2010a). Each of these 
two enzymes can convert SI to SIS and readily degraded further via MI metabolic pathway. 
Transcription of iolX is induced by SI addition in the growth medium of cells, and cells were 
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grown in the presence of SI as a carbon source (Morinaga et al., 2010a). On the other hands, 
transcription of iolW is constitutive and its inactivation was not relevant to on the growth 
depending on SI (Morinaga et al., 2010a). These results suggested that IolX is a catabolic 
enzyme essential for SI metabolism, but IolW may have another physiological function such 
as to generate SIS from SI with NADPH oxidation. 
 
 
Fig. 1-2. MI catabolic pathway and functional activities of the B. subtilis iol genes. B. subtilis iol 
genes proven to encode the enzymes involved in the various reaction steps of the MI catabolic 
pathway are shown. Compound: [1], MI; [2], DCI; [3], 2KMI; [4], 1KDCI; [5], THcHDO; [6], 5DG; 
[7], DKG; [8], DKGP; [9], DHAP; [10], MSA; [11], acetyl-CoA. Carbon numbering is defined for MI, 
2KMI, THcHDO, 5DG, DKG, and DKGP. 
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Inositol dehydrogenases belong to the Gfo/Idh/MocA family 
 Inositol dehydrogenases in B. subtilis, such as IolG, IolW and IolX, belong to the 
Gfo/Idh/MocA family, representing a number of glucose-fructose oxydoreductases, rhizopine 
catabolic MocA proteins, and inositol 2-hydrogenases. The members of this protein family 
have a typical structural feature, consisting of an N-terminal typical Rossmann fold domain 
for binding dinucleotide and a C-terminal β-sheet extensive domain for binding substrate and 
oligomerization, and the enzyme active site is located forming the pocket between of two 
domain (vanStraaten et al. 2010; Taberman et al. 2016). Almost of this family proteins 
require NAD(P)
+
 as its hydride donor or acceptor. Likewise in most of NAD
+
-dependent 
enzyme, the cofactor is thought to interact with the specific structure in Rossmann fold region 
with consensus amino acid sequence containing the three glycine ‘GxGxxG’ motif, where x is 
any amino acid residue, and conserved aspartate (sometimes glutamate) was detected after 
approximately 20 residues in the sequence downstream of the ‘GxGxxG’ motif (Lesk, 1995). 
The first and second Gly residues may be relevant to nucleotide binding and the third one 
could be responsible for packing of the helix against the β-sheet, and the Asp residue in 
downstream is supposed to bind to the ribose of the adenosine moiety of NAD
+
 through a 
hydrogen bond (Lesk, 1995).  
 
Aim of this study 
The author aimed at elucidation of function and regulation of inositol 
dehydrogenases in B. subtilis. In Chapter 2, he describes his investigation of transcriptional 
regulation factor encoded by degA for transcription of iolX. In Chapter 3, he describes 
identification of a novel SI dehydrogenase YulF (renamed IolU) with a co-factor property 
depending on NADP
+
 similar to IolW. Finally, in Chapter 4, he describes his trial to examine 
possible structural determinants for co-factor specificity of inositol dehydrogenases. 
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Chapter 2 
Bacillus subtilis DegA is a transcriptional repressor of iolX encoding 
NAD
+
-dependent scyllo-inositol dehydrogenase 
 
Bacillus subtilis is able to utilize at least three inositol stereoisomers as carbon sources, 
MI, SI, and DCI, respectively. Most enzymes involved in inositol catabolism are encoded 
by the iolABCDEFGHIJ operon, including the product of iolG, MI dehydrogenase, 
which is regulated by the IolR repressor. The NAD
+
- and NADP
+
-dependent SI 
dehydrogenases are encoded by iolX and iolW, respectively, which are transcribed 
independently. Recently another NADP
+
-dependent SI dehydrogenase encoded by iolU 
was identified (refer to Chapter 3). Even in the absence of functional iolX, the presence 
of SI or MI in the growth medium induces the transcription of iolX through an 
unknown mechanism. Immediately upstream of iolX, there is an operon encoding two 
genes, yisR and degA, each of which could encode a transcriptional regulator. Here the 
author performed inactivation analysis of yisR and degA and found that degA likely 
encodes a repressor of iolX transcription. The coding sequence of the degA was 
expressed in Escherichia coli as a His-tagged fusion protein that bound specifically in 
vitro to two sites within the iolX promoter region. Genetic evidences allowed us to 
speculate that SI and MI might possibly be the intracellular inducers antagonizing DNA 
binding of DegA, however in vitro experiments failed to support this possibility. 
 
Introduction 
Epimerization of the hydroxyl groups of cyclohexane-1,2,3,4,5,6-hexol (inositol) 
generates nine different stereoisomers, with the most abundant form in nature being cis-
1,2,3,5-trans-4,6-cyclohexanehexol (myo-inositol, MI), which is an essential component of 
phosphatidylinositol in the cell membranes of eukaryotes and exists as myo-inositol 
hexakisphosphate (phytic acid) in plant seeds (Irvine & Schell, 2001). Other inositol 
stereoisomers occur rarely in nature, although some exert specific, physiologically important 
effects. For example, D-chiro-inositol (DCI) and its 3-O-methyl derivative, D-pinitol, are 
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beneficial for patients with hyperglycemia or polycystic ovary syndrome (Larner, 2002; 
Iuorno et al., 2002), and scyllo-inositol (SI) directly interacts with beta-amyloid peptides to 
inhibit their aggregation in the brain and block the development of Alzheimer disease 
(McLaurin, 2000). 
Bacillus subtilis efficiently utilizes inositol stereoisomers such as MI, DCI, and SI as 
carbon sources (Yamaoka et al., 2011). The iolABCDEFGHIJ operon encodes the enzymes 
that catabolize MI and DCI (Fig. 2-1). Two inositol transporters are encoded by iolF and iolT 
for MI and SI uptake (Yoshida et al., 2002; Morinaga et al., 2010b). MI dehydrogenase, 
encoded by iolG, converts MI to scyllo-inosose (SIS) and reduces NAD
+
 in the first reaction 
of the catabolic pathway (Yoshida et al., 1997). IolG reacts on both MI and DCI but not on SI 
(Ramaley et al., 1979). The iol operon and iolT are regulated by the IolR transcriptional 
repressor, which is antagonized by the product of IolC kinase (Yoshida et al., 2000; Yoshida 
et al.,2008). In contrast, the inositol dehydrogenases IolX and IolW are specific for SI and 
require NAD
+
 and NADP
+
, respectively (Morinaga et al., 2010a). Each enzyme converts SI 
to SIS, which is the same product generated from MI by IolG. Transcription of iolX is 
induced by addition of SI to the growth medium as the sole carbon source (Morinaga et al., 
2010a). Transcription of iolW is constitutive but does not contribute to growth on SI, 
suggesting that IolX is essential for the catabolism of SI and that IolW is required for other 
reactions such as the generation of SI from SIS (Morinaga et al., 2010b; Yamaoka et al., 
2011). 
The mechanism underlying the regulation of iolX to degrade SI is unknown. Within 
the B. subtilis genome, yisR and degA reside upstream of iolX and are predicted to encode 
transcriptional regulators that belong to the AraC/XylS and LacI families, respectively (Fig. 
2-1). Members of the AraC/XylS family include positive regulator such as AdaA that induce 
the alkA and ada operons in B. subtilis (Morohoshi et al., 1993). In contrast, most members 
of the LacI family are negative regulators, such as CcpB (Chauvaux et al., 1998), KdgR (Lin 
& Shaw, 2007), ExuR (Mekjian et al., 1999), and LacR (Daniel et al., 1997) in B. subtilis. 
Transcriptome analysis revealed that yisR and degA are transcribed from a single operon 
(Nicolas et al., 2012). The function of YisR is unknown, and has never been studied for its 
regulatory function. On the other hand, DegA was named after the discovery that the 
recombinant form produced in Escherichia coli accelerates the degradation of glutamine 
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phosphoribosyl pyrophosphate amidotransferase, implying that it might be a protease (Bussey 
& Switzer, 1993). However, its sequence similarities to regulatory proteins encoded by cytR, 
lacI, galR, and purR of E. coli and ccrP of B. subtilis suggest that it might have stimulated 
the production of a protease (Bussey & Switzer, 1993). In the present study, the author 
therefore investigated the possible involvement of YisR and DegA in the regulation of iolX. 
The author shows that degA encodes a transcriptional repressor that binds to the promoter 
region of iolX. 
 
Fig. 2-1. Inositol metabolic pathway in Bacillus subtilis (top) and organization of the relevant genes 
(bottom). D-chiro- (DCI), myo- (MI), and scyllo-inositol (SI) are converted to scyllo-inosose (SIS) and 
degraded further via the metabolic pathway involving the series of Iol enzymes. 1KDCI, 1-keto-D-
chiro-inositol. 
 
Mrthods 
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Bacterial strains, plasmid and growth conditions 
 Bacterial strains and plasmids used in this study are listed in Table 2-1. B. subtilis 
strain 168 is our standard strain for the study on inositol catabolism. The mutant strains 
BFS1058, BFS3018 and BFS3047 were constructed from strain 168 and acquired from the 
National BioResource Project, National Institute of Genetics, Japan. BFS1058 has a 
pMUTIN2 (lacZ lacI amp erm; Vagner et al. 1998) integration to disrupt iolW (Morinaga et 
al., 2010a). BFS3018 has a pMUTIN4 (lacZ lacI amp erm; Vagner et al. 1998) integration to 
disrupt iolX which allows us to monitor iolX expression by -galactosidase activity 
(Morinaga et al., 2010a). BFS3047 also has another pMUTIN4 integration to place the 
coding region of yisR-degA operon under the control of the spac promoter (Pspac) inducible 
in the presence of IPTG and activity of the yisR promoter is monitored by -galactosidase 
activity. The other B. subtilis mutant strains were constructed as described below. E. coli 
strains DH5α (Sambrook & Russell, 2001), HVC45 (Jannière et al., 1985), and BL21(DE3) 
(Merck Millipore) served as hosts for plasmid construction and expression of C-terminal 
His6-tagged, respectively. 
E. coli strains were maintained in Luria–Bertani (LB) medium, and B. subtilis strains 
were maintained using tryptose blood agar base (Becton Dickinson) or S6 liquid medium 
(Fujita & Freese, 1981) containing 0.5% casamino acids (Becton Dickinson). Plasmids 
pMD20 (Takara Bio) and pET-30a (Merck Millipore) served as vectors for TA-cloning and 
His6-tag construction, respectively. Antibiotics used as required were as follows: 
erythromycin (0.5 μg ml−1), ampicillin (50 μg ml−1), and kanamycin (50 μg ml−1). Media 
were supplemented with 1 mM IPTG or X-gal as required. All bacteria were cultured at 37°C 
with rotary shaking at 150 rpm. 
 
Construction of Bacillus subtilis mutants 
Strain TM045 was designed to possess the intact yisR transcriptionally fused to lacZ, 
while TM046 has the disrupted yisR fused to lacZ. Both have degA under the control of 
Pspac, which was thus expressed in the presence of IPTG. TM045 and TM046 were 
constructed as follows. DNA fragments were amplified using the PCR and specific primers 
(Table 2-2) containing EcoRI and BamHI restriction sites (degAEcoRI-F/degABamHI-R for 
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strain TM045; yisREcoRI-F/yisRBamHI-R for strain TM046). Each PCR product was 
cleaved using EcoRI and BamHI and then ligated to plasmid pMUTIN4 that was cleaved 
using cognate enzymes. The resulting plasmids, designated pM4degA or pM4yisR, were 
integrated into the chromosome of B. subtilis 168 to confer resistance against erythromycin to 
yield B. subtilis strains TM045 and TM046, respectively. 
 
Table 2-1. Bacterial strains and plasmids 
Strain or plasmid Description Source or reference 
E. coli   
   DH5α supE44 ΔlacU169 (Φ80 lacZΔM15) hsdR17 
recA1 gyrA96 thi-1 relA 
Sambrook & Russell 
(2001) 
HVC45 ThrA1 leu-6 thi-1 lacY1 ton21 supE44 hsdR rpsL Jannière et al. (1985) 
   BL21(DE3) F
- 
ompT hsdSΒ (rΒ
-
mΒ
-
) dcm gal (DE3) tonA Merck Millipore 
B. subtilis   
   168 trpC2 Laboratory stock 
BFS1058 trpC2 iolW::pMUTIN2 Morinaga et al. (2010a) 
BFS3018 trpC2 iolX::pMUTIN4 Morinaga et al. (2010a) 
BFS3047 trpC2 PyisR-lacZ Pspac-yisR-degA National BioResource 
Project, National 
Institute of Genetics, 
Japan 
TM045 trpC2 yisR-lacZ Pspac-degA This study  
TM046 trpC2 yisR::pMUTIN4 Pspac-degA This study 
Plasmid   
pMUTIN2 Integration vector containing spac promoter ,lacZ, 
lacI, Amp, and Erm 
Vagner et al. (1998) 
pMUTIN4 Integration vector containing spac promoter, lacZ, 
lacI, Amp, and Erm 
Vagner et al. (1998) 
pM4yisR pMUTIN4 derivative containing an internal part 
of yisR coding region 
This study 
pM4degA pMUTIN4 derivative containing a head part of 
degA coding region 
This study 
pM4iolX pMUTIN4 derivative containing a tail part of iolX 
coding region 
This study 
pMD20 TA-cloning vector, amp Takara Bio 
pET-30a pET system expression vector, kan Merck Millipore 
pET-degA pET-30 derivative to express degA-His6 This study 
pET-yisR pET-30 derivative to express YisR-His6 This study 
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Enzyme assay 
NAD
+
-dependent SI dehydrogenase activities in cell extracts were measured 
spectrophotometrically with increase in absorbance at 340 nm with generation of NADH as 
described (Morinaga et al., 2010a). -Galactosidase activities in cell extracts were 
determined as previously described (Yoshida et al., 2000). 
 
RNA techniques 
B. subtilis strains 168, BFS3047, TM045, and TM046 were grown at 37°C with 
shaking in S6 medium containing 0.5% casamino acids (Becton Dickinson) with or without 
MI or SI (10 mM each), and 1 mM IPTG was added as required. Total RNAs were extracted 
from the cells and purified as previously described (Yoshida et al., 1999). 
The RNA samples were subjected to northern blot analysis using DIG-labeled RNA 
probe specific for iolX. The RNA probe was prepared as follows: A DNA fragment 
corresponding to part of the iolX-coding region was PCR-amplified using strain 168 DNA as 
a template and the primers NiolX and NiolXDIG (Table 2-2) to introduce a T7 RNA 
polymerase promoter sequence at their 3′-termini. The PCR product was used as the template 
for in vitro transcription using a DIG RNA labeling kit (SP6/T7) (Roche Diagnostics, Basel, 
Switzerland) to produce the DIG-labeled RNA probe. Cellular RNAs were separated using 
gel electrophoresis, transferred to a positively-charged nylon membrane (Roche Diagnostics), 
and hybridized using the DIG-labeled probe as per the manufacturer’s instructions. Hybrids 
were detected using a DIG luminescence detection kit (Roche Diagnostics). 
B. subtilis strain 168 was grown at 37°C with shaking in S6 medium containing 0.5% 
casamino acids (Becton Dickinson) with or without 10 mM SI. Total RNAs were extracted 
from the cells and purified as previously described (Yoshida et al., 1999). Primer extension 
was performed to identify the transcriptional start site of the iolX transcript (Yoshida et al., 
1997). Reverse transcription initiated from the PiolX400-R primer (Table 2-2) labeled at the 
5′-terminus using a Megalabel kit (Takara Bio) and [-32P]ATP (PerkinElmer). DNA from 
strain 168 used as the template for the dideoxy sequencing reactions, which initiated from the 
same end-labeled primer used for ladder preparation, was prepared by PCR using the primers 
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PiolX400-F/PiolX400-R (Table 2-2). 
 
Table 2-2. Oligonucleotide primers. 
Primer Sequence (5′→3′)* 
yisREcoRI-F GGAATTCCTTTCTCCCGGTCTTGAACA 
yisRBamHI-R CGCGGATCCCGAGCGACAGATCCTTGATT 
degAEcoRI-F GGAATTCTAACCAGACGAGGGATGAAC 
degABamHI-R CGCGGATCCCGTAATCGGTGCTGCAAATC 
degANdeI-F GGGAATTCCATATGATGAAAACAACAATTTACGATGT 
degAXhoI-R CCGCTCGAGTCATGTGTTGAGCGGTGATG 
yisRNdeI-F GGGAATTCCATATGATGCCTCGCATCCTGTTTAC 
yisRXhoI-R CCGCTCGAGTTATTGAACTTTCCGGCTGAC 
NiolX CGGATCGACGCTGGAGAAA 
NiolXDIG TAATACGACTCACTATAGGGAGCCGATAGGATGGTCACAT 
iolX (-200)-F ATGAGCGGGTTTTTTCATTATG 
iolX (-1)-R GTCCCATCCTCTCCTTTATC 
yisR (-200)-F CAAGTAAGCGAAAATAATGAGAA 
yisR (-1)-R TTGAATCATCCTCCTTTTTAAGT 
GMSA-Nega-F TTTTCACGGGCCGCTGCT 
GMSA-Nega-R CTCAGCATCTGGAAAATCCC 
PiolX400-F TAGCCCAGCCGATAAAAGAG 
PiolX400-R TAACCGAGCCTTCCTAATCC 
iolX (-250)-F GAGCTTGTAGTCAGACATTCT 
iolX (+50)-R TAACCGAGCCTTCCTAATCC 
[FAM] iolX (-250)-F [FAM]GAGCTTGTAGTCAGACATTCT 
[FAM] iolX (+50)-R [FAM]TAACCGAGCCTTCCTAATCC 
*Restriction enzyme recognition sites and T7 RNA polymerase promoter-tag sequence are underlined 
and italicized, respectively. 
 
Plasmid construction 
DNA fragments corresponding to the coding regions of degA and yisR were 
amplified from B. subtilis 168 genomic DNA by PCR using the respective primers 
degANdeI-F/degAXhoI-R and yisRNdeI-F/yisRXhoI-R with generation of NdeI and XhoI 
 14 
 
sites at the 5′- and 3′-termini of each amplicon, respectively (Table 2-2). Each PCR product 
was ligated to the arms of pMD20 (Takara Bio) using a Mighty TA-cloning kit (Takara Bio), 
and was used to transform E. coli DH5α, which was then cultured on LB plates containing 
ampicillin, IPTG, and X-gal. White colonies were selected, and plasmid DNAs were 
subjected to sequence analysis using an ABI PRISM 3100 Genetic Analyzer (Thermo Fisher 
Scientific). The recombinant plasmids with the correct sequences were digested using NdeI 
and XhoI, and the restriction fragments were ligated to the arms of NdeI/XhoI-cleaved pET-
30a to generate pET-degA or pET-yisR, which were used to transform E. coli BL21(DE3) to 
produce C-terminal His6-tagged proteins DegA-His6 and YisR-His6, respectively. 
 
Protein production and purification 
E. coli BL21(DE3) transformed with pET-degA or pET-yisR was inoculated into LB 
medium containing kanamycin and cultured at 37°C with shaking. The recombinant proteins 
were synthesized using 1 mM IPTG when the optical density of the culture reached OD660= 
0.35, and the culture was further incubated for 2 h at 37°C with shaking; the cells were 
harvested and disrupted by sonication. DegA-His6 and YisR-His6 were purified from cell 
lysates using a TALON metal-affinity resin (Takara Bio) according to the manufacturer’s 
instructions. 
 
Gel mobility shift assay 
Gel mobility shift assays were performed according to Meyer & Rensing (2009). To 
prepare the probe, 200-bp sequences of the iolX and yisR promoter regions were PCR-
amplified using the specific primers iolX (-200)-F/iolX (-1)-R and yisR (-200)-F/yisR (-1)-R, 
respectively (Table 2-2). A negative control 100-bp fragment representing a segment of the 
iolW-coding region was amplified using the primers GMSA-Nega-F/GMSA-Nega-R (Table 
2-2). The DNA probes were incubated in binding buffer [10 mM Tris-HCl (pH 8.0), 1 mM 
DTT, 10 mM KCl, 5 mM MgCl2, 10% glycerol, and 5 µg ml
−1
 poly d(I-C)] at 37°C for 30 
min with and without varying amounts of DegA-His6 or YisR-His6. DNA–protein complexes 
were separated using nondenaturing polyacrylamide gels in TAE buffer. The probe DNAs in 
 15 
 
the gel were stained using SYBR Green for 30 min, and the bands were visualized using 
Chemi Doc XRS+ with Image Lab software (Bio-Rad). 
 
DNase I footprint assay 
PCR reactions were used to amplify 5′-6-[FAM]-labeled DNA fragments containing 
the iolX promoter region (300 bp) from the DNA of strain 168 using the specific primers 
[FAM] iolX (-250)-F/iolX (+50)-R and iolX (-250)-F/[FAM] iolX (+50)-R for labeling the 
sense and antisense strands, respectively (Table 2-2). Each differentially 5′-6-[FAM]-labeled 
DNA fragment was incubated in binding buffer with and without various amounts of DegA-
His6 at 37°C for 30 min. DNase I was added to digest the DNA for 5 min, and the reaction 
was stopped by adding 0.25 M EDTA. DNAs were extracted using a PCR purification kit 
(Promega). DNA sequencing of the sense and antisense strands employed the primers iolX (-
250)-F and iolX (+50)-R, respectively, using the Thermo Sequenase Dye Primer Manual 
Cycle Sequence Kit (USB). The DNA samples were consigned to Sigma-Aldrich, where they 
were analyzed using an ABI 3130xl Genetic Analyzer and ABI Gene Mapper Software Ver. 
4.0 (Thermo Fisher Scientific). 
 
Results 
SI and MI induce the transcription of iolX 
In the standard strain 168, NAD
+
-dependent SI dehydrogenase activity was induced 
in the presence of SI, while it completely disappeared in strain BSF3018 with the inactivation 
of iolX through pMUTIN4 integration (Fig. 2-2a). It was previously reported that BSF3018 
did not grow depending on SI as the sole carbon source (Morinaga et al., 2010a). Therefore, 
SI induced iolX to produce NAD
+
-dependent SI dehydrogenase responsible for physiological 
utilization of SI in B. subtilis. Although iolX is not required for the MI catabolism (Morinaga 
et al., 2010a), MI was also able to induce NAD
+
-dependent SI dehydrogenase activity, 
indicating that MI could induce iolX. The induction in response to MI was slightly reduced 
but essentially unaltered by the inactivation of iolW in strain BFS1058. In addition, the 
induction by SI and MI was completely abolished in the presence of additional glucose, 
 16 
 
suggesting that iolX could be under catabolite repression (Fig. 2-2a).  
 
Fig. 2-2. NAD
+
-dependent SI dehydrogenase activity and -galactosidase activities of strains of B. 
subtilis. (a) NAD
+
-dependent SI dehydrogenase assays. Strains 168 (lanes 1-6), BFS3018 (lanes 7 and 
8), BFS1058 (lanes 9-11), and TM045 (lanes 12 and 13) were inoculated into S6 medium containing 
0.5% casamino acid (lanes 1, 7, 9 and 12) cultured to an OD600 of 1.0. As indicated, the culture media 
were supplemented with the carbon sources (10 mM each); glucose (lane 2), MI (lanes 3 and 10), SI 
(lanes 4, 8, 11, and 13), glucose and SI (lane 5), and glucose and MI (lane 6). Values are means + SD 
obtained from three independent assays. ND, not detected (< 0.001). (b) Organization of the iolX 
locus in BFS3018. (c) -Galactosidase assays. Strain BFS3018 was inoculated into S6 medium 
containing 0.5% casamino acid (lane 1) cultured to an OD600 of 0.5. As indicated, the culture media 
were supplemented with the carbon sources (10 mM each); glucose (lane 2), MI (lane 3), SI (lane 4), 
and glucose and SI (lane 5). The data shown are representing more than three independent 
experiments with similar results. 
 17 
 
 
On the other hand, in strain BFS3018, iolX was inactivated but its transcription could 
be monitored by expression of lacZ for -galactosidase activity instead (Fig. 2-2b). As shown 
in Fig. 2-2c, in the presence of SI, the -galactosidase activity was induced without 
functional iolX, and this induction was almost abolished by additional glucose, confirming its 
catabolite repression. Moreover, MI also induced the -galactosidase activity even on the 
iolX-null background as well as the NAD
+
-dependent SI dehydrogenase activity in strain 168 
with functional iolX. 
These results indicated that the transcription of iolX was induced efficiently by SI 
and also partially by MI. The induction did not require the enzymatic function of IolX, 
implying that an intracellular inducer compound might not be an intermediate produced 
during the SI catabolism. In addition, the induction in the presence of MI might not be 
depended on the functional iolW. 
 
Expression of degA is required to regulate iolX transcription in response to SI 
As shown in Fig. 2-3, the Northern blot analysis confirmed that the transcription of 
iolX in strain 168 was induced indeed in the presence of SI.  
Immediately upstream of iolX, there is an operon encoding two genes, yisR and degA 
(Nicolas et al., 2012), each of which could encode a transcriptional regulator; yisR and degA 
are predicted to encode transcriptional regulators that belong to the AraC/XylS and LacI 
families, respectively (Fig. 2-1). In the mutant strain BFS3047, the transcription of yisR-degA 
operon is controlled by Pspac and requires addition of IPTG to the medium (Fig. 2-3a). When 
strain BFS3047 was grown without IPTG, neither yisR nor degA was expressed, and the 
Northern blot analysis revealed that the transcription of iolX was constitutive even in the 
absence of SI. In contrast, when IPTG was added, the iolX transcript disappeared in the 
absence of SI but induced in response to SI similarly as observed in the parental strain 168. 
The results indicate that YisR, DegA, or both could regulate the induction of iolX in medium 
containing SI. 
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Fig. 2-3. Northern blot analysis of iolX transcription and -galactosidase activities in strains of B. 
subtilis. (a) Organization of the yisR-degA locus of strains 168, BSF3047, TM045, and TM046. 
Numbers indicate nucleotide positions relative to the transcription initiation site +1 (P2) (Fig. 2-5). (b) 
Northern blot analysis of iolX transcription. RNA samples were prepared from strains 168 (lanes 1–2), 
BFS3047 (lanes 3–6), TM046 (lanes 7–10), and TM045 (lanes 11–14), which were grown in S6 
medium containing 0.5% casamino acids alone (lanes 1, 3, 7, and 11) and in the same medium 
supplemented with 10 mM SI (lanes 2, 4, 8, and 12), 1 mM IPTG (lanes 5, 9, and 13), or 10 mM SI 
and 1 mM IPTG (lanes 6, 10, and 14). The arrowhead indicates the iolX transcripts. The lower panel 
shows the ribosomal RNA (16S and 23S) loading control. (c) -Galactosidase activities in strains of 
B. subtilis. Strains 168 (lanes 1-4), BSF3047 (lanes 5-8), TM046 (lanes 9-12), and TM045 (lanes 13-
16) were inoculated into S6 medium containing 0.5% casamino acid (lanes 1, 5, 9, and 13) cultured to 
an OD600 of 0.5. As indicated, the culture media were supplemented with 1 mM IPTG (lanes 2, 6, 10, 
and 14), 10 mM SI (lanes 3, 7, 11, and 15), or 1 mM IPTG and 10 mM SI (lane 4, 8, 12, and 16). 
Values are means + SD obtained from three independent assays. 
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To determine if YisR and DegA directly regulate iolX, the author generated the 
additional mutant strains TM045 and TM046 (Fig. 2-3a). In TM045, only degA is placed 
under the control of Pspac and thus induced in the presence of IPTG. In strain TM046, yisR is 
disrupted by the pMUTIN4 integration while degA is expressed under the control of Pspac. 
Therefore, degA is expressed both inTM046 and TM045 only if IPTG is present, and yisR 
could be transcribed under the control of the original promoter of yisR-degA operon in 
TM045 but never functions in strain TM046. 
The Northern blot analyses revealed that, in TM046 without functional yisR, iolX 
was transcribed in the absence of IPTG even in the absence of SI. However, the transcription 
was shut off completely in the presence of IPTG alone, but was induced in response to the 
additional SI (Fig. 2-3b). These results indicate that the regulation of iolX in response to SI 
occurred when only DegA was expressed without YisR, suggesting that DegA alone could 
function as a repressor of iolX transcription. On the other hand, in TM045 where yisR and 
degA are expressed separately (Fig. 2-3b), in the presence of IPTG, DegA was produced to 
repress transcription of iolX, which was induced in response to SI similarly as in TM046. 
However, a fewer amount of iolX transcript was produced in the presence of both IPTG and 
SI, implying that the artificial expression of degA driven by Pspac in TM045 might be too 
excess to be inactivated by the intracellular inducer. Otherwise, the separately expressed 
degA and yisR might cause some effects on the induction level of iolX. In TM045, when 
DegA was not produced in the absence of IPTG, the NAD
+
-dependent SI dehydrogenase 
activities were constitutive and very high (Fig. 2-2a), indicating that DegA was indispensable 
for repression of iolX. Although the activity was elevated in the presence of SI, this might be 
due to the leaky expression of degA under the control of Pspac (Vagner et al., 1998) 
Expression of the lacZ reporter derived from pMUTIN4 gives -galactosidase 
activity in BFS3047, TM046, and TM045, which represents transcription driven by the 
promoter of yisR-degA operon (Fig. 2-3c). The -galactosidase activities in the cells of strains 
BFS3047 and TM045 were weak and constant independently of the presence of IPTG and SI, 
which were almost comparable to those found in the standard strain 168. The results 
indicated that transcription driven by the promoter of yisR-degA operon is kept at lower levels 
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generally. However, to our surprise, the significant activities appeared in the cells of strain 
TM046 grown in the presence of IPTG. In TM046, yisR was inactivated but degA was 
induced in the presence of IPTG. The results suggested that DegA might induce transcription 
driven by the promoter of yisR-degA operon when functional YisR was absent. 
 
DegA binds to the iolX promoter region 
DegA-His6 and YisR-His6 (Fig. 2-4) were tested for binding to DNA probes 
containing either of the promoter region of iolX or yisR-degA operon. Gel mobility shift 
assays revealed that DegA-His6 only formed a complex with the probe of iolX promoter 
region (Fig. 2-4). The DegA–DNA complexes formed distinct bands, and the higher 
molecular weight bands increased with increasing concentrations of DegA-His6 (Fig. 2-4). 
The results indicate that the iolX probe may comprise at least two DegA-binding sites with 
different affinities (Fig. 2-4). In contrast, YisR-His6 did not bind detectably to either probe 
(data not shown). 
 
Fig. 2-4. Electrophoretic gel mobility shift assay. (a) Purification of DegA-His6 (DegA) and YisR-His6 
(YisR). The purified proteins migrated to form the respective bands in SDS-PAGE with the expected 
sizes (arrowheads on the right). M, size markers. (b) Results of electrophoretic gel mobility shift assay 
of the interaction of DegA-His6 with the iolX promoter probe. The DNA -fragment probes 
corresponding to the 200-bp iolX promoter region (200 bp of iolX) and the negative control 100-bp 
fragment derived from the iolW-coding region (100 bp of N. C.) were incubated with various 
concentrations of DegA-His6 as indicated (nM of DegA) and subjected to non-denaturing PAGE. The 
bands representing DegA-His6–DNA complexes are indicated as the DegA–iolX complex. 
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Identification of the two DegA-binding sites within the iolX promoter region 
A primer extension experiment (Fig. 2-5) was conducted to determine two 
transcriptional start sites P1 and P2 for the iolX transcript. Only a small amount of transcript 
from P1 was detected even in the absence of SI, but it was significantly induced together with 
the P2 transcript in response to SI. Their corresponding -35 and -10 regions were deduced to 
serve as iolX promoters P1 and P2 (Fig. 2-6). 
 
 
Fig. 2-5. Primer extension analysis of the iolX 
transcript. Total RNA samples extracted from strain 168 
grown in S6 media containing 0.5% casamino acids and 
supplemented without (lane1) or with 10 mM SI (lane2) 
were reverse transcribed to generate cDNA. Lanes G, 
A, T and C are dideoxy sequencing ladders 
corresponding to the reverse transcript (lower strand) 
generated from the same primer used for the reverse 
transcription. The partial nucleotide sequence of upper 
strand of the promoter region is shown on the left where 
identified two 5’-ends of the transcripts corresponding 
to the transcription start sites (P1 and P2) are bold face 
as indicated with arrowheads. 
 
DegA-binding sites within the iolX promoter region identified using DNase I 
footprint analysis (Fig. 2-6) revealed that DegA bound with different affinities to two regions 
(Fig. 2-6). The sequences TCTTTTGAGAAAGCGCTTGCGCAAAAT (spanning +4 to +30 
bp, position numbers assigned relative to P2) and AGAGAAAACGCTTTCTCAAAG 
(spanning +68 to +88 bp) were protected at lower and higher concentrations of DegA, 
respectively (Fig. 2-6). The protected stretch of the higher affinity region extended 7 bp 
upstream and 1 bp downstream compared with that of the lower affinity site. The two 
protected regions contained the conserved sequence AGAAARCGCTTKCKCAAA (where R 
= A or G and K = G or T), which may represent a core recognition sequence required for 
DegA binding. A plausible cre site for CcpA/P-Ser-HPr binding predicted previously 
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(Marciniak et al., 2012) was found overlapping the lower affinity region, which might be 
involved in the catabolite repression (Fig. 2-6). 
 
Fig. 2-6. DNase I footprinting of DegA-His6 on the iolX promoter region. DNase I footprinting of the 
upper (a) and lower (b) strands. The sequence data are shown on the top, and below are fragment 
analysis data acquired using various concentrations of DegA-His6 as indicated on the right. (c) 
Summary of DNase I footprinting data. Transcription initiation sites +1 (P1) and +1 (P2) and their 
corresponding −35 and −10 regions are indicated. The protected regions with higher and lower 
affinities are indicated by black and gray bars, respectively. The conserved sequences within the 
protected regions are boxed. The cre sites predicted are indicated by a dashed bar between the upper 
and lower strand sequences within the two regions for DegA binding. 
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Discussion 
B. subtilis strains possess at least three types of SI dehydrogenases encoded by iolX, 
iolW (Morinaga et al., 2010a), and iolU (Kang et al., 2017). IolX requires NAD
+
 and both 
IolW and IolU need NADP
+
 as cofactor. The author showed here that iolX was induced in the 
presence of SI and/or MI (Fig. 2-2), which plays an indispensable role in the utilization of SI 
as a carbon source for growth (Morinaga et al., 2010a). Transcription of iolW is constitutive, 
and IolW can convert SI into SIS in vitro but does not contribute to growth depending on the 
availability of SI as the carbon source (Morinaga et al., 2010a). IolU is produced 
constitutively and generally at low levels (Nicolas et al., 2012) and was not able to 
dehydrogenate SI but only reduce SIS into SI (Kang et al., 2017). The author hypothesized 
that yisR and degA, which are located and cotranscribed (Nicolas et al., 2012) immediately 
upstream of iolX, might encode the regulator(s) of iolX transcription (Fig. 2-1). YisR is a 
member of the AraC/XylS family, which includes mainly positive transcription regulators 
(Morohoshi et al., 1993), and DegA is a member of the LacI family of negative transcription 
regulators (Fukami-Kobayashi, 2003), which contain the typical helix-turn-helix motif, 
characteristic of a DNA-binding domain (Weickert & Adhya, 1992). 
In the cells of strain TM046 expressing degA but without yisR, regulation of iolX in 
response to SI occurred normally, suggesting that YisR might not directly contribute to the 
regulation of iolX transcription (Fig. 2-3b). Usually, the regulatory function of the AraC/XylS 
family members requires specific cofactors; for example, B. subtilis GabR needs binding with 
pyridoxal 5′-phosphate to exert its regulatory function (Belitsky, 2004). Therefore, the author 
hypothesized that one of MI, SI, and SIS might be a cofactor of YisR. However, the author 
were unable to detect the binding of YisR-His6 to the probes for the two promoter regions of 
iolX and yisR-degA operon in the presence and absence of any of them (data not shown). The 
result suggested that YisR might not bind to the two promoter regions and that none of MI, 
SI, and SIS might be a cofactor under the present conditions. On the other hand, as shown 
Fig. 2-3c for strain TM046, the -galactosidase activities representing transcription driven by 
the yisR-degA promoter were induced when DegA was produced alone in the absence of 
YisR, and this induction occurred independently of the presence of SI. As mentioned above, 
not only DegA but also YisR failed to bind to the promoter region of yisR-degA operon in 
vitro. At this moment, therefore, the author is unable to elucidate the phenomena, but it is 
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likely that YisR and DegA might act on the yisR-degA promoter indirectly in the negative and 
positive ways, respectively. Obviously, further studies are required to clarify the regulation of 
yisR-degA promoter involving YisR and DegA. 
The data presented here indicate that degA encodes a repressor that binds to two sites 
within the iolX promoter region (Figs. 2-4 and 2-6). iolX encodes the NAD
+
-dependent SI 
dehydrogenase responsible for physiological SI catabolism (Morinaga et al., 2010a). Even 
when the author functionally inactivated iolX in BF3018 by inserting pMUTIN4, 
transcription of iolX was prominently elevated in media containing SI (Fig. 2-2c). SI may not 
be converted efficiently to SIS by NADP
+
-dependent SI dehydrogenase IolW, which is 
constitutively produced (Morinaga et al., 2010a). Accordingly, it is conceivable that the 
possible inducer compound interacting DegA might not be an intermediate produced during 
SI catabolism. Previously, it was demonstrated that MI was converted into SI through the 
coupling reactions involving IolG and IolW; the former dehydrogenates MI into SIS with 
reduction of NAD
+
, and the latter reduces SIS into SI with oxidation of NADPH (Yamaoka et 
al., 2011). Therefore, in the presence of MI in culture medium, it is possible that a certain 
amount of SI could appear interacellularly when both IolG and IolW functioned 
simultaneously. In fact, the author found that iolX was also induced in the presence of MI, but 
this induction was almost unaffected by the inactivation of iolW (Fig. 2-2a). Recently another 
NADP
+
-dependent SI dehydrogenase encoded by iolU was identified (Kang et al., 2017). 
This enzyme is not as active as IolW but able to convert SIS into SI only if it was 
overexpressed. Therefore, IolU might not be involved in the possible conversion of MI into 
SI. All these genetic evidences led us to speculate that mainly SI and secondarily MI could be 
the intracellular inducers that antagonize the binding of DegA to the iolX promoter region, 
allowing the induction of iolX. However, the gel mobility shift experiments revealed that 
neither SI, MI, nor SIS antagonized the specific DNA binding of DegA-His6 in vitro (data not 
shown). As shown in Fig. 2-3, in TM045 expressing DegA and YisR separately, a fewer iolX 
transcript was produced in the presence of both IPTG and SI, implying that YisR might cause 
some effects on the induction level of iolX. Therefore, another set of the gel mobility shift 
experiments involving not only DegA-His6 but also YisR-His6 was conducted. Nevertheless, 
none of the SI, MI, or SIS still caused any effects on DNA binding of DegA-His6 (data not 
shown). Consequently, in this study the author could not fully elucidate the mechanism 
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underlying the induction of iolX but only its repression by binding of DegA to the DNA of 
iolX promoter region. 
The author shows here that DegA bound with different affinities to the two sites 
within the iolX promoter region. The high affinity site was located from positions +4 to +30 
within the sequence TCTTTTGAGAAAGCGCTTGCGCAAAAT, and the low affinity site 
was located from +68 to +88 within the sequence AGAGAAAACGCTTTCTCAAAG (Fig. 
2-6). Most members of the LacI family preferentially require a palindromic sequence within 
their DNA-binding sites (Fukami-Kobayashi, 2003). Comparison between the sequences of 
the two DegA-binding sites identified the relatively conserved sequence 
AGAAARCGCTTKCK with the potential perfect palindrome AGAAAGCGCTTTCT. 
However, this palindrome is not present in either of the two binding sites that differ in two or 
one positions in the high and low affinity binding sites, respectively. Therefore, the consensus 
palindrome is not the only determinant of DegA binding, although the sequences extending 
from the conserved stretch may contribute to high affinity binding of DegA to its target 
sequence. Within the B. subtilis genome, there are 22 sites with a sequence similar to the 
conserved consensus sequence (maximum two different positions, data not shown). At least 
seven of the 22 sites are located close to promoter regions, including the one of iolX 
promoter. Thus, DegA may regulate six additional promoters and therefore drive the 
transcription of at least the genes (products) as follows; glpT (glycerol-3-phosphate 
permease), ycsA (putative enzyme similar to 3-isopropylmalate dehydrogenase), acoR 
(transcriptional activator of acetoin utilization genes), yrbE (another member of the 
Gfo/Idh/MocA family paralogs including iolG, iolU, iolW, and iolX) (Kang et al., 2017), 
menA (1,4-dihydroxy-2-naphthoate octaprenyltransferase), and bglS (endo--1,3-1,4 
glucanase). Our future course will focus on determining the mechanisms of transcriptional 
regulation of these genes and their involvement in SI metabolism. 
Expression of iolX for NAD
+
-dependent SI dehydrogenase activity in 168 as well as 
for the β-galactosidase activity in strain BFS3018 was almost completely repressed in 
response to glucose even in the presence of SI and MI, indicating that iolX could be under 
catabolite repression (Fig. 2-2a and c). The plausible cre site predicted overlapping the lower 
affinity region for DegA binding (Fig. 2-6) might be involved in the catabolite repression. In 
addition, we noticed that part of the conserved sequence AGAAARCGCTTKCK for DegA 
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binding was quite similar to the one WGNAANCGNTTNCW for CcpA/P-Ser-HPr biding, 
which was less conserved that the one for DegA (Fujita, 2009). And the sequence 
AGAAAGCGCTTGCGC within the higher affinity region for DegA binding was also similar 
to the cre site consensus (Fig. 2-6). These observations suggested that the two DegA-binding 
sites might have dual functions for transcriptional repression of iolX through the interaction 
with DegA in the absence of inducer(s) and with CcpA/P-Ser-HPr in the presence of glucose. 
Since iolX functions for catabolism of SI as a minor alternative carbon source, it makes sense 
that this gene is regulated by the global catabolite repression (Fujita, 2009). 
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Chapter 3 
Bacillus subtilis iolU encodes an additional NADP
+
-dependent  
scyllo-inositol dehydrogenase 
 
B. subtilis genes iolG, iolW, iolX, ntdC, yfiI, yrbE, yteT, and yulF belong to the 
Gfo/Idh/MocA family. The functions of iolG, iolW, iolX, and ntdC were demonstrated 
experimentally. However, none of the others are known. It was previously reported that 
the B. subtilis cell factory simultaneously overexpressing iolG and iolW was enabled to 
achieve bioconversion of MI into SI. YulF shares a significant similarity with IolW, but 
its transcriptional abundance did not correlate to that of iol genes. However, 
overexpression of yulF instead of iolW in the B. subtilis cell factory resulted in 
conversionof MI into SI, suggesting its similar function to iolW. The recombinant His6-
tagged YulF was produced in E. coli to convert SIS into SI depending on NADPH in 
vitro. The author has thus identified yulF encoding an additional NADP
+
-dependent SI 
dehydrogenase to rename it as iolU. 
 
Introduction 
A number of microorganisms, including Aerobacter aerogenes (Berman & 
Magasanik, 1966), Bacillus subtilis (Fujita et al., 1991), Corynebacterium glutamicum 
(Krings et al., 2006), Cryptococcus melibiosum (Vidal-Leiria & van Uden, 1973), 
Geobacillus kaustophilus (Yoshida et al., 2012), Lactobacillus casei (Yebra et al., 2007), 
Rhizobium leguminosarum (Poole et al., 1994), Sinorhizobium fredii (Jiang et al., 2001), and 
Sinorhizobium meliloti (Galbraith et al., 1998), are able to utilize inositol as the sole carbon 
source. Bacterial inositol metabolism involves inositol dehydrogenases, which belong to the 
Gfo/Idh/MocA family, including many members of NAD(P)
+
-dependent dehydrogenases [or 
NAD(P)H-dependent oxidoreductases] (Taberman et al., 2016). The enzymes of this family 
typically possess an N-terminal domain with a Rossmann fold for binding dinucleotides and a 
C-terminal domain with one of six or nine β-sheet strands bundled for oligomerization 
(Taberman et al., 2016).  
Inositol is a six-fold alcohol of cyclohexane, and there are nine distinct stereoisomers 
epimerizing the six hydroxyl groups. Among the nine isomers, myo-inositol (MI) is the most 
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abundant in nature, while the others are relatively rare. However, some bacteria are able to 
degrade some of these rare isomers as alternative carbon sources. For instance, B. subtilis has 
the capacity to catabolize not only MI but also scyllo-inositol (SI) and D-chiro-inositol (DCI). 
B. subtilis iolG is the seventh gene in the iol operon, which coordinates on the chromosome  
from 4,075,785 to 4,076,819 nt, and encodes MI dehydrogenase required for the first step in 
converting MI into scyllo-inosose (SIS) with the reduction of NAD
+
, and SIS is further 
degraded to metabolic intermediates such as dihydroxyacetone phosphate and acetyl 
coenzyme A (Fig. 3-1) (Fujita et al., 1991). IolG also acts on DCI to produce 1-keto-D-chiro-
inositol (1KDCI), which is isomerized to SIS by IolI and thus degraded further (Fig. 3-1) 
(Yoshida et al., 2006). Additionally, the metabolism of SI involves enzymes encoded by iolW 
(a.k.a. yvaA from 3,443,359 to 3,444,432 nt) and iolX (a.k.a. yisS from 1,164,370 to 
1,165,398 nt) (Morinaga et al., 2010a). IolW and IolX are NADP
+
- and NAD
+
-dependent SI 
dehydrogenases, respectively (Morinaga et al., 2010a). Under physiological conditions, SI is 
converted into SIS by IolX and degraded similar to MI and DCI.  
IolW can efficiently reduce SIS into SI. SI is a therapeutic agent for Alzheimer’s 
disease, which received fast-track designation from the U.S. Food and Drug Administration 
(alzforum.org). Previously, it was demonstrated that B. subtilis can produce SI from MI. To 
construct the necessary B. subtilis cellular machinery, most of the enzymes involved in 
inositol catabolism were eliminated but both iolG and iolW were overexpressed In this cell 
factory, two-step reactions took place to achieve the efficient production of SI. Specifically, 
the first reaction is the conversion of MI into SIS by IolG and the second reaction reduced 
SIS into SI via IolW (Yamaoka et al., 2011). The overall conversion of MI into SI depends on 
the efficiency of the second reaction, which requires NADPH (Morinaga et al., 2010a). 
 The genes iolG, iolW, iolX, ntdC, yfiI, yrbE, yteT, and yulF are paralogs within the B. 
subtilis genome. Among them, as described above, iolG, iolW, and iolX were functionally 
identified as inositol dehydrogenases. It was recently reported that ntdC encodes NAD
+
-
dependent glucose-6-phosphate dehydrogenase for the biosynthesis of the antibiotic 
kanosamine (Vetter et al., 2013). However, the roles of yfiI, yrbE, yteT, and yulF remain to be 
investigated. The author found that iolW and yulF share a significant similarity to each other 
and subsequently hypothesized that yulF, which coordinates on the chromosome from 
3,196,906 to 3,197,892 nt, encodes an additional NADP
+
-dependent SI dehydrogenase. In 
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this study, the author confirmed this hypothesis of the role of yulF as a functional paralog of 
iolW, which was renamed as iolU. 
 
Fig. 3-1. Inositol metabolic pathway in B. subtilis. 
 
Materials and Methods 
Bacterial strains, plasmids, and growth conditions. 
Bacterial strains and plasmids used in this study are listed in Table 3-1. Escherichia 
coli strains DH5α (Sambrook & Russell, 2001) and BL21(DE3) (Takara Bio, Otsu, Japan) 
were used as hosts for plasmid construction and expression of C-terminal His6-tag fusion 
proteins, respectively. B. subtilis and E. coli strains were maintained in Luria-Bertani (LB) 
medium. Plasmids pMD20 (Takara Bio) and pET-30a (Takara Bio) were used as the cloning 
vectors for TA-cloning and His6-tag fusion constructs, respectively. When required, reagents, 
including 50 μg/ml ampicillin and 50 μg/ml kanamycin, 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG), and 0.004% 5-bromo-4-chloro-3-indolyl-β-D-
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galactopyranoside (X-gal) were added into the culture media. All bacteria were incubated at 
37°C with rotary shaking at 150 rpm. 
 
Table 3-1. Bacterial strains and plasmids used in this study. 
Strains and plasmids Description Source or reference 
Strains   
B. subtilis   
   168 trpC2 Laboratory stock 
KU104 aprE::[PrpsO-iolWerm] ΔiolABCDEF ΔiolHIJ 
ΔiolR ΔiolX trpC2 
Tanaka et al. (2013) 
KU401 ΔiolW::neo ΔiolABCDEF ΔiolHIJ ΔiolR ΔiolX 
trpC2 
Present study 
KU402 aprE::[PrpsO-yulF(iolU) erm] ΔiolW::neo 
ΔiolABCDEF ΔiolHIJ ΔiolR ΔiolX trpC2 
Present study 
MYI04 ΔiolABCDEF ΔiolHIJ ΔiolR ΔiolX trpC2 Tanaka et al. (2013) 
E. coli   
   BL21(DE3) F
-
 ompT hsdSΒ (rΒ
-
mΒ
-
) dcm gal (DE3) tonA Takara Bio 
   DH5α supE44 ΔlacU169 (Φ80 lacZΔM15) hsdR17 
recA1 gyrA96 thi-1 relA 
Sambrook & Russell 
(2001) 
   
Plasmids   
   pMD20 Amp Takara Bio 
   pET-30a Kan Takara Bio 
   pETiolU kan PT7-yulF(iolU)-his6 Present study 
   pETiolW kan PT7-iolW-his6 Morinaga et al.  
(2010a) 
   pETiolX kan PT7-iolX-his6 Morinaga et al.  
(2010a) 
 
Mutant construction. 
Strains KU401 (ΔiolW::neo) and KU402 [aprE::PrpsO-yulF(iolU) ΔiolW::neo] were 
constructed from MYI04. Briefly, to construct KU401, two PCR fragments corresponding to 
the 5′- and 3′-stretches flanking iolW (Fig. 3-2A) were amplified from the chromosomal DNA 
of strain 168 with primer pairs of iolW-1-F/iolW-1-R and iolW-2-F/iolW-2-R, respectively 
(Table 3-2). Another PCR fragment of the neomycin resistant gene cassette (Fig. 3-2A) was 
amplified from DNA of strain BEST7613 (Watanabe et al., 2005) with the primer pair Neo-
F/Neo-R (Table 3-2). These three PCR fragments were designed to form a single recombinant 
PCR DNA fragment with the neomycin resistant gene cassette flanked by the 5′- and 3′-
stretches of iolW (Fig. 3-2A). Thus, these fragments were ligated via recombinant PCR with 
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the iolW-1-F/iolW-2-R primer pair. The recombinant PCR fragment was used to transform 
MYI04 to be neomycin resistant in order to yield KU401 (ΔiolW::neo) (Fig. 3-2A).  
 
Table 3-2. Primers used in this study. 
Primer Sequence (5′→3′) 
aprE-iolW-P1 caatctttacgctttgcgttctcg 
aprE-iolW-P3 cgcaaacaacaagctgatccac 
aprE-iolW-P4 gacattcggcacactccttttc 
iolU-F ggtaactggggctaaatatgatttgggctataatttagctatatcatgcaaaagg 
iolU-NdeI-F gggaattccatatggtgatacgttttgcaataatag 
iolU-R gtggatcagcttgttgtttgcgggcatttgcacgcgggcgg 
iolU-XhoI-R ccgctcgagttaagcttgatcagcagggta 
iolW-1-F ctactgctttgacgcagtgctg 
iolW-1-R ccctatttatagacgctgtgccgtgatgtcatgattttgct 
iolW-2-F gagccatcagcctaaagaagatgtcatccgcatcattga 
iolW-2-R gcaacttcgtacagtatggcaac 
Neo-F cacagcgtctataaataggg 
Neo-R cttctttaggctgatggctc 
PrpsO-R ccaaatcatatttagccccagttacc 
Note: Restriction enzyme sites are underlined. 
 
To construct KU402, three PCR fragments were prepared as well. The first PCR 
fragment contained a 3′-stretch flanking aprE (part of yhfN), the erythromycin resistant gene, 
and the rpsO promoter (PrpsO) (Fig. 3-2B) and was amplified from DNA of strain KU104 
(Tanaka et al., 2013) with the aprE-iolW-P1/PrpsO-R primer pair (Table 3-2). The second 
fragment for the 5′-stretch flanking aprE containing yhfO (Fig. 3-2B) was amplified from 
DNA of strain KU104 with the aprE-iolW-P3/aprE-iolW-P4 primer pair (Table 3-2). Finally, 
the third fragment containing the reading frame of yulF (Fig. 3-2B) was amplified from DNA 
of strain 168 with the iolU-F/iolU-R primer pair (Table 3-2). These three PCR fragments 
were ligated by the recombinant PCR with the primer pair aprE-iolW-P1/aprE-iolW-P4 (Fig. 
3-2B). The recombinant PCR fragment was used to transform KU401 to be erythromycin 
resistant, thus yielding KU402 [aprE::PrpsO-yulF(iolU) ΔiolW::neo] for artificial 
overexpression of yulF under the control of PrpsO (Fig. 3-2B). 
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Fig. 3-2. Schematic presentation of the modified chromosomal loci of strains KU401 (A) and KU402 
(B). 
 
Plasmid construction. 
To produce His6-tagged YulF in E. coli, the plasmid pETiolU was constructed. 
Briefly, a PCR fragment corresponding to the coding region of yulF was amplified from DNA 
of strain 168 with the iolU-NdeI-F/iolU-XhoI-R primer pair (Table 3-2) to generate NdeI and 
XhoI sites at the head and tail, respectively. The PCR product was inserted into the TA-
cloning site of pMD20, which was introduced into E.coli DH5α using a TA-cloning kit 
(Takara Bio). The pMD20-derivative plasmid was digested with NdeI and XhoI, and the insert 
DNA was isolated and ligated to the arms of pET-30a, which was previously linearized with 
the same restriction enzymes. The recombinant plasmid was used to transform DH5α to 
become kanamycin resistant, and correct construction of the plasmid designated as pETiolU 
was confirmed by sequencing. pETiolU was introduced into E. coli BL21(DE3) for 
production of His6-tagged YulF. The plasmids pETiolW and pETiolX were previously 
constructed to produce His6-tagged IolW and IolX in E. coli, respectively (Morinaga et al., 
2010a). 
 
Measurement of MI and SI in culture media. 
Aliquots of bacterial cultures were extracted at 0, 12, 24, and 48 h after the 
inoculation of MYI04, KU401, and KU402 into the bioconversion medium, which consisted 
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of 2% (w/v) Bacto Soytone (Becton, Dickinson and Co., Sparks, MD, USA), 0.5% (w/v) 
Bacto yeast extract (Becton, Dickinson and Co.), 0.2% (w/v) glucose, and 1% (w/v) MI 
(Tanaka et al., 2013). After removal of bacterial cells by brief centrifugation, the culture 
media were passed through Amicon Ultra-0.5 ml 3 K Centrifugal Filter (Millipore, Billerica, 
MA). The eluent was measured by high performance liquid chromatography (HPLC; 
LaChrom Elite: HITACHI High Technologies, Tokyo, Japan) with a COSMOSIL Sugar-D 
column (4.6 x 250 mm) (Nacalai tesque, Kyoto, Japan) kept at 25°C and a flow rate at 2 
ml/min of acetonitrile/water (80/20). Inositol isomers were detected by a refractive index 
detector, and the refractive index units were used to calculate their concentrations. 
 
Enzyme production, purification, and assays. 
E. coli BL21(DE3) cells carrying pETiolU, pETiolW, or pETiolX were inoculated 
into LB medium containing kanamycin and allowed to grow at 37°C with shaking. At an 
OD660 of 0.35, 1 mM IPTG was added into the medium to induce production of the His6-
tagged enzymes, and the culture was further incubated for 2 h at 37°C with shaking. Then, 
the cells were harvested and disrupted by brief sonication. From the cell lysate, His6-tagged 
enzymes were purified by Ni-Co affinity chromatography according to supplier’s instructions 
(Takara Bio).  
The purified His6-tag fusion enzymes were assayed spectrophotometrically for 
inositol dehydrogenase activity. Briefly, 50 μg of each purified enzyme, YulF (IolU), IolW, 
and IolX, was combined in 1 ml of reaction mixture containing 100 mM Tris-HCl (pH 7.5), 
500 μM of cofactor (NAD+ or NADP+), and 30 mM of substrate (SI or MI). The enzyme 
activity was measured by following the increase in absorbance at 340 nm associated with the 
reduction of NAD(P)
+
 at 37°C for 5 min (Ramaley et al., 1979).  
To evaluate the ability of YulF (IolU) and IolW to convert SIS into SI, the reactions 
were performed in 100 μl of mixtures containing 50 μg of enzyme (IolW or YulF), 50 mM 
potassium phosphate buffer (pH 7.5), 80 mM SIS, and 80 mM cofactor (NADPH or NADH) 
and incubated at 37°C for 2 h. To terminate the reactions, AG 50W-X8 (H
+
 form) (Bio-Rad) 
was added and incubated at 50°C for 10 min. After brief centrifugation, supernatants were 
analyzed by HPLC to determine inositol abundance as described above for measurement of 
MI and SI in culture media. 
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Results and Discussion 
YulF was selected as the candidate functional paralog of IolW 
B. subtilis IolG, IolW, IolX, YfiI, NtdC, YrbE, YteT, and YulF enzymes are paralogs 
and belong to the Gfo/Idh/MocA family, which includes many members of NAD(P)
+
-
dependent dehydrogenases [or NAD(P)H-dependent oxidoreductases] (Taberman et al., 
2016). Among these paralogs, IolW shares the highest homology with YrbE and YulF: 22.3% 
identity/350 aa overlap and 25.3%/253 aa, respectively. However, YrbE exhibited a much 
higher homology to IolX (37.7%/337 aa), suggesting that it may be more related to IolX than 
IolW. In addition, phylogenetic analysis also revealed YulF as most closely related to IolW 
(Fig. 3-3). Therefore, the author selected YulF as a candidate IolW paralog. 
 The transcriptional expression of iolW was previously reported as constitutive 
(Morinaga et al., 2010a) but recently was shown to be elevated under certain stressful 
conditions (Nicolas et al., 2012) and also under the regulation of sigma B (Höper et al., 2005). 
yulF has been shown to be transcribed in an approximately constitutive manner and generally 
at low levels (Nicolas et al., 2012); however, its regulation is unknown. Both genes are not 
induced in the presence of inositol (Morinaga et al., 2010a), and their expression profiles do 
not correlate to those of other iol genes, implying their principal roles might not be involved 
in inositol metabolism. However, IolW was previously identified as an NADP
+
-dependent SI 
dehydrogenase and capable of efficiently reducing SIS into SI (Morinaga et al., 2010a; 
Yamaoka et al., 2011; Tanaka et al., 2013).  
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Fig. 3-3. Similarity among B. subtilis iolG, iolW, iolX, ntdC, yfiI, yrbE, yteT, and yulF. Pairwise 
alignment of amino acid sequences of the respective gene products was performed using the Clustal 
W program (http://www.genome.jp/tools/clustalw/) with the default slow/accurate settings, and the 
phylogenetic tree was made via unrooted phylogenetic analysis. 
 
Overproduction of YulF compensated in activation of IolW  
Previously, it was demonstrated that B. subtilis can produce SI from MI (Yamaoka et 
al., 2011; Tanaka et al., 2014). To construct the first generation of the B. subtilis cell factory 
of strain TM039 (Yamaoka et al., 2011), iolR encoding the transcriptional repressor was 
inactivated to allow constitutive expression of both the iolABCDEFGHIJ operon and iolT for 
the MI transporter (Yoshida et al., 2002). iolE encoding SIS dehydratase, which is relevant 
for the second step of inositol catabolism, was mutated to abolish further degradation of SIS 
(Yamaoka et al., 2011), and iolX was knocked out to prevent dehydrogenation of the 
produced SI (Yamaoka et al., 2011). Thus, in TM039, both iolG for MI dehydrogenase and 
iolW for SI dehydrogenase are constitutively active along with iolT to enable the two-step 
reactions required for SI production from MI, which involve the first reaction converting MI 
into SIS by IolG and the second reaction to reduce SIS into SI by IolW (Yamaoka et al., 
2011). In the B. subtilis second generation of cell factory strain MYI04, iolABCDEF, iolHIJ, 
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iolR, and iolX were deleted from the chromosome (Tanaka et al., 2013). Finally in strain 
KU106, SI production was further improved with simultaneous overexpression of iolG and 
iolW to achieve complete conversion of MI into SI (Tanaka et al., 2013).  
 
Fig. 3-4. MI consumption and SI generation by MYI04 (A), KU401 (B), and KU402 (C). Aliquots of 
culture media were extracted at 0, 12, 24, and 48 h after the inoculation of bacteria and analyzed for 
inositol as described in the text. Values are means with SD from three independent experiments. 
 
The author chose strain MYI04 as the parental strain in this study, because the 
factory strain KU106 possessed two copies of iolW (Tanaka et al., 2013) and could not be 
used to investigate the possible function of yulF in an iolW-null background. In MYI04, the 
single copies of iolG and iolW were expressed constitutively. As the cells of MYI04 
consumed MI during cultivation in the bioconversion medium, they produced SI almost 
equivalently to consume MI, resulting in 5 g/L SI produced with consumption of about 6 g/L 
MI within 48 h (Fig. 3-4). This result indicated the conversion of MI into SI via the two-step 
reactions catalyzed by IolG and IolW. 
Regarding strain KU401, a derivative of MYI04 constructed to inactivate iolW 
(ΔiolW::neo), production of SI was almost disabled, with only a trace of SI apparent in 24 h 
that slightly increased afterwards. Thus, the author has shown iolW as indispensable for 
efficient SI production in MYI04. However, albeit weak, KU401 enabled SI production 
 37 
 
without IolW. Interestingly, within 48 h, KU401 consumed up to 0.2 g/L MI, which was 
much more than SI produced. Such data suggested that most of the consumed MI might be 
converted into SIS but not further. The conversion of MI to SIS causes reduction of NAD
+
 
into NADH, and NADH could be used for energy acquisition through the respiratory chain 
and/or for the reverse reaction of IolG reducing SIS into MI to regenerate NAD
+
. However, 
the author could not detect SIS in the culture medium (data not shown), and the author 
speculated that a certain amount of SIS might accumulate in the cell. To experimentally 
confirm this, further studies are warranted.  
The strain KU402 [aprE::PrpsO-yulF(iolU) ΔiolW::neo] was constructed from 
KU401 by introducing an additional copy of yulF placed on the aprE locus under the control 
of PrpsO, one of the strongest and constitutive promoters within the genome (Nicolas et al., 
2012). Thus, in this strain, additional yulF was overexpressed in the iolW-null background to 
enhance YulF function. As shown in Fig. 3-4, KU402 achieved significant production of SI 
up to 3 g/L in 48 h. The author demonstrated that yulF could encode an enzyme capable of 
converting SIS into SI like iolW. In the previous study, however, strain KU104 
overexpressing iolW under the control of PrpsO, in a MYI04 background, produced 8 g/L SI 
in 48 h (Tanaka et al., 2013). Such large differences of produced SI may imply that the 
enzyme encoded by yulF is less efficient than IolW. 
As aforementioned, endogenous yulF is generally expressed at lower levels (Nicolas 
et al., 2012), and thus, the author posited that intracellular YulF in KU401 may be in such low 
abundance to exert enzymatic function. As discussed above, however, since a certain amount 
of SIS was able to accumulate in KU401, endogenous YulF may partly convert SIS into SI, 
resulting in the observed small amounts of SI found in the medium. 
 
YulF (IolU) converted SIS into SI depending on NADPH 
His6-tagged YulF was produced in E. coli and purified, and then assessed for inositol 
dehydrogenase activities with various substrates (MI, SI, and SIS) and cofactors (NAD
+
 and 
NADP
+
), and compared with the two SI dehydrogenases previously identified, namely IolW 
and IolX, which were also His6-tagged.  
Regarding capacity to dehydrogenate inositol, enzymatic activities were evaluated by 
reduction of cofactors. As previously reported, IolX functioned as expected to dehydrogenate 
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SI (Table 3-3). In addition, IolW exhibited an ability to dehydrogenate SI depending on 
reduction of NADP
+
. However, YulF failed to act on both MI and SI substrates as reduction 
of NAD
+
 or NADP
+
 was not observed in our study (Table 3-3). The results suggested that 
YulF does not function to dehydrogenate inositol in vitro. 
 
Table 3-3. Inositol dehydrogenase activities of purified enzymes. 
Note: ND, not detected (< 0.001). 
 
 On the other hand, with respect to reducing SIS into SI, in vitro SI production was 
analyzed by HPLC, where SI and SIS were respectively detected at peaks with retention 
times at 6.6 and 10.25 min (Fig. 3-5A). YulF produced SI from SIS in a NADPH-dependent, 
but not on NADH-dependent, manner and did not produce MI (Fig. 3-5C and D). Both IolW 
and YulF produced SI in the presence of NADPH; however, the amounts of produced SI 
differed for more than 8-fold; IolW and YulF produced 1.7 and 0.2 g/L of SI, respectively 
(Fig. 3-5B and C). The results indicated that YulF can convert SIS into SI, albeit at a 
diminished capacity of IolW. Moreover, these results coincided with YulF’s decreased SI 
production observed in strain KU402. 
Overexpression of yulF contributed to SI production in vivo, and purified YulF 
exerted in vitro activity to convert SIS into SI in the presence of NADPH. Therefore, the 
author proposed yulF to be renamed to iolU, which encodes another NADP
+
-dependent SI 
dehydrogenase in addition to iolW. As described above, the transcriptional expression of iolU 
is generally maintained at low levels (Nicolas et al., 2012), and its function was only 
discerned via overexpression. Accordingly, the evolutionary implication of iolU within the B. 
subtilis genome is still unclear and warrants further investigation. As stated previously, iolW 
Enzyme Substrate Cofactor Activity (μmol min−1 mg−1) 
IolU 
MI 
NAD
+
 ND 
NADP
+
 ND 
SI 
NAD
+
 ND 
NADP
+
 ND 
IolW SI 
NAD
+
 ND 
NADP
+
 0.048 
IolX SI 
NAD
+
 0.092 
NADP
+
 ND 
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is constitutively expressed (Morinaga et al., 2010a) and regulated by sigma B under stressful 
conditions (Höper et al., 2005; Nicolas et al., 2012). These facts collectively imply that iolW 
may be involved in reduction of not only SIS but also various oxidized compounds 
manifested upon stressful conditions. In addition, the author demonstrated that purified IolU 
was not able to dehydrogenate SI but only reduce SIS in vitro, suggesting that IolU could 
specialize in reducing carbonyl group(s) in its substrates. Therefore, under physiological 
conditions, these enzymes identified as NADP
+
-dependent SI dehydrogenase may primarily 
function as NADPH-dependent oxidoreductase. Examining IolU for its substrate specificity 
beyond SIS may provide a more holistic picture of its role under physiological conditions. 
Intriguingly, the paralog IolG was shown to act upon MI, DCI, D-glucose, and D-xylose, 
suggesting broad substrate specificity for this group of enzymes (Ramaley et al., 1979). 
Therefore, IolU may reduce oxidized compounds under where IolW alone is insufficient, and 
this may be a potential reason as to why iolU has been evolutionarily maintained in the B. 
subtilis genome. 
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Fig. 3-5. HPLC analysis of substrates (SIS) and products (SI) in the YulF (IolU) and IolW reaction. 
Reduction of SIS was performed and analyzed by HPLC as described in the text. (A) Standards of 
0.25% of SIS (the peak with retention times at 6.6 min) and SI (the peak at 10.25 min), (B) Reduction 
of SIS by IolW with NADPH, (C) Reduction of SIS by YulF (IolU) with NADPH, and (D) Reduction 
of SIS by YulF (IolU) with NADH. The experiments were repeated at least three times with similar 
results, and a representative data set is shown. 
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Chapter 4 
Switching cofactor specificity of inositol dehydrogenases in Bacillus subtilis 
 
Members belonging to the Gfo/Idh/MocA family proteins, including IolG, IolX and IolW, 
share a consensus NAD
+
/NADP
+
 specific binding region with the ‘GxGxxG’ motif. In 
addition, an aspartate residue for NAD
+
- and an arginine/serine residue for NADP
+
-
dependent enzymes were detected for its key amino acid in 18-19 downstream of 
‘GxGxxG’ motif. The author made mutant enzymes by chimeric mutagenesis and site-
directed mutagenesis in trial to switch the cofactor specificities of IolG, IolX and IolW; 
the former two are NAD
+
-dependent and the last latter NADP
+
-dependent. In chimeric 
mutagenesis, the author replaced the N-terminal regions containing the ‘GxGxxG’ motif 
of IolW with those of IolG and IolX, but failed to produce any mutant with detectable 
activity. Therefore, the author changed the strategy to conduct the site-directed 
mutagenesis to replace some of key amino acid residues. One of the mutants of IolG, 
IolG-D35R, exhibited lowered activity acting on MI with reduction of NAD
+
, while 
another mutant IolG-Q38R elevated the MI dehydrogenase activity with NAD
+
 and was 
weak but still reactive with NADP
+
. The 35
th
 aspartate residue could be one of the key 
residues, and the arginine residue of IolG-Q38R might have made a phosphate pocket to 
increase NADP
+
 binding but its effect was limited. On the other hand, none of the IolW 
derivatives exhibited a detectable activity, and no other studies to determine cofactor 
specificity of IolW have been reported so far. It would be worthwhile to conduct further 
site-directed mutagenesis on IolW to elucidate the relationship between its structure and 
function. 
 
Introduction 
Alzheimer’s disease (AD) is one of the most common types of dementia, which is an 
age related neurodegenerative disorder in brain. In 2016, 47.5 million people have dementia 
in the world and new 7.7 million people are increasing per year, and this number is reached 
more than 131 million in 2050 (‘Dementia’, 2016; Prince et al., 2016). The two hallmark 
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pathologies in the AD are the extracellular plaque deposits of the β-amyloid peptide (Abeta) 
and the flame-shaped neurofibrillary tangles of the microtubule binding protein tau (Murphy 
& Iii, 2010). Especially in the brains of AD patients, Abeta oligomers aggregate cause 
damage of hippocampal synaptic plasticity and memory deficits (Tanaka et al., 2015).  
Intriguingly, it was shown that SI can directly interact with Abeta, which is the 
hallmark of Alzheimer’s patients to cause damage of hippocampal synaptic plasticity and 
memory deficits, to inhibit its aggregation and block the development of AD (McLaurin et al., 
2000). However, SI exists much more rarely in nature, but is sometime found in several 
organisms, including barley seeds (Kinnard et al., 1995), Terahymena vorax (Riggs et al., 
2007), and early stage of flower bud in chrysanthemum (Ichimura et al., 2000). In mammals, 
some SI exists in the kidney and brain (Sherman et al., 1968). In any case, since this 
compound is rare and difficult to obtain, development of an efficient production method has 
been eagerly awaited. 
In the previous studies, firstly Yamaoka and the colleagues (2011) investigated to 
convert MI into SI by a B. subtilis cell factory coupling the IolG and IolW reactions, and 
secondly Tanaka et al. (2013) was successful to elevate the conversion efficiency further. It 
was suggested that the intercellular levels of cofactors could be unbalanced by the coupling 
reactions involvng IolG and IolW; the former converts NAD
+
 to NADH, whereas the latter 
NADPH to NADP
+
. Especially, regeneration of NADPH was suggested as one of the key 
determinants for the conversion efficiency (Tanaka et al. 2013). 
IolG, IolX, and IolW, the three major inositol dehydrogenases in B. subtilis, belong 
to the Gfo/Idh/MocA family of enzymes, which interconvert a hydroxyl group and a carbonyl 
group of the substrates involving reduction and oxidation of cofactors, NAD(P)
+
 and 
NAD(P)H, respectively (vanStraaten et al. 2010). Enzymes of this family share a structural 
feature consisting of an N-terminal Rossmann fold and a C-terminal β-sheet extensive 
domain (Taberman et al., 2016). The enzyme active site is usually found between the two 
domains. Moreover, most of the Gfo/Idh/MocA family members require NAD(P)
+
 as their 
cofactors. Naturally, these enzymes possess a glycine rich region between β1 and α1 which is 
known as the NAD(P)
+
-binding cofactor site, where the ‘GxGxxG’ sequence is often 
conserved. And 18~19 amino acid residues downstream from the ‘GxGxxG’ motif, an 
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aspartate residue and an arginine/serine residue are conserved between 2
nd
 β-sheet (β2) and 
2
nd
 α-helix (α2) for interaction with NAD+ and NADP+, respectively (Fig. 4-1)(Lesk, 1995). 
Based on these previous findings, some experimental demonstrations were ever 
reported for changing cofactor specificities of arabinitol dehydrogenase (Bae et al., 2010), 
formate dehydrogenase (Hoelsch et al., 2013), xylitol dehydrogenase (Watanabe et al., 2005), 
ketol-acid reductoisomerase and alcohol dehydrogenase (Bastian et al., 2011). Likewise, in 
this chapter, the author tried to switch cofactor specificity of IolG and IolW. 
 
Fig. 4-1. The amino acid sequence of IolG, IolX and IolW. NAD-dependent enzyme (IolG and IolX) 
have aspartate residue in the end of β2 and NADP-dependent enzyme (IolW) has arginine residue in 
front of α2. 
 
Materials and methods 
Bacterial strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this Chapter are listed in Table 4-1. E. coli 
strains DH5α (Sambrook & Russell, 2001), and BL21(DE3) (Merck Millipore) served as 
hosts for plasmid construction and expression of C-terminal His6-tagged, respectively. B. 
subtilis 168 is the standard strain, the chromosome DNA of which was used as the source 
template for PCR cloning of the mutant derivatives of inositol dehydrogenases. Bacterial 
strains were maintained in Luria–Bertani (LB) medium, and cultivated at 37°C with rotary 
shaking at 150 rpm. 
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Table 4-1. Bacterial strains and plasmids 
Strain or plasmid Description Source or reference 
E. coli   
   DH5α 
supE44 ΔlacU169 (Φ80 lacZΔM15) hsdR17 
recA1 gyrA96 thi-1 relA 
Sambrook & Russell 
(2001) 
   BL21(DE3) F
-
 ompT hsdSΒ (rΒ
-
mΒ
-
) dcm gal (DE3) tonA Merck Millipore 
B. subtilis   
   168 trpC2 Laboratory stock 
Plasmid   
pMD20 Amp Takara Bio 
pET-28b(+) Kan Merck Millipore 
pET-30a Kan Merck Millipore 
pET-iolG kan, Plac-iolG This study 
pET-iolX kan, Plac-iolX Morinaga et al. (2010a) 
pET-iolW kan, Plac-iolW Morinaga et al. (2010a) 
pET-XW3949 kan, Plac-iolXW3949 This study 
pET-XW5664 kan, Plac-iolXW5664 This study 
pET-XW5763 kan, Plac-iolXW5763 This study 
pET-GW5663 kan, Plac-iolGW5663 This study 
pET-G-D35R kan, Plac-iolG (D35R) This study 
pET-G-Q38R kan, Plac-iolG (Q38R) This study 
pET-W-T46D kan, Plac-iolW (T46D) This study 
pET-W-T46D S47P kan, Plac-iolW (T46D, S47P) This study 
pET-W-T46D S47P R48L kan, Plac-iolW (T46D, S47P, R48L) This study 
pET-W-T46D S47V kan, Plac-iolW (T46D, S47V) This study 
pET-W-T46D S47V R48N kan, Plac-iolW (T46D, S47V, R48N) This study 
pET-W-R48D kan, Plac-iolW (R48D) This study 
 
Plasmids pMD20 (Takara Bio) and pET-30a (Merck Millipore) served as vectors for 
TA-cloning and His6-tag construction, respectively. Media were supplemented with 1 mM 
IPTG, X-gal, and antibiotics [ampicillin (50 μg ml−1) and kanamycin (50 μg ml−1)] as 
required.  
 
Construction of mutant derivatives of inositol dehydrogenases 
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To alternate the cofactor specificity of inositol dehydrogenases, the author took two 
ways of mutagenesis; one was the chimeric mutagenesis swapping the corresponding regions 
of iolG, iolW and iolX, and the other was the site-directed mutagenesis replacing amino acid 
residues. All the mutagenesis was done based on the recombinant PCR technique, and various 
pairs of specific PCR primers were designed as listed in Table 4-2.  
 
Table 4-2. Primers lists of this study 
Primer Sequence (5’-3’) 
iolG-NcoI-F agtggctgtccatgagtttacgta 
iolG-NdeI-F gggaattccatatgagtttacgtattggcgtaattg 
iolW-NdeI-F gggaattccatatgttgataacgcttttaaagggga 
iolX-NdeI-F gggaattccatatggtggaacatcaagtaagatgt 
iolG56-R atttgtgatttcttcaagctcatgcggataaaccgtcgcgtttaa 
iolW63(G)-F ttaaacgcgacggtttatccgcatgagcttgaagaaatcacaaat 
iolX39-R atcccgtttcacttcttctgttaacggatcaccgacacaaa 
iolW49(X)-F tttgtgtcggtgatccgttaacagaagaagtgaaacgggat 
iolX57-R gtcatttgtgatttcttcaagctcctctgaccatttttcgatacc 
iolW64(X)-F ggtatcgaaaaatggtcagaggagcttgaagaaatcacaaatgac 
iolX56-R atttgtgatttcttcaagctcatgtgaccatttttcgataccgag 
iolW63(X)-F ctcggtatcgaaaaatggtcacatgagcttgaagaaatcacaaat 
iolG D35R –F gcagcttcttgattaacccgcgttacagctacaatttccg 
iolG D35R –R cggaaattgtagctgtaacgcgggttaatcaagaagctgc 
iolG Q38R –F ccttttgtgcagcttcccgattaacatccgttacagctaca 
iolG Q38R –R tgtagctgtaacggatgttaatcgggaagctgcacaaaagg 
iolW T46D –F acttcttctgtccgtgaatccatgattttgctgatttgatatt 
iolW T46D –R aatatcaaatcagcaaaatcatggattcacggacagaagaagt 
iolW T46D S47P -F cttcttctgtccgcggatccatgattttgctgatttgatatt 
iolW T46D S47P -R aatatcaaatcagcaaaatcatggatccgcggacagaagaag 
iolW T46D S47PR48L -F cacttcttctgttaacggatccatgattttgctgatttgatatt 
iolW T46D S47P R48L -R aatatcaaatcagcaaaatcatggatccgttaacagaagaagtg 
iolW T46D S47V -F acttcttctgtccgaacatccatgattttgctgatttgatatt 
iolW T46D S47V -R aatatcaaatcagcaaaatcatggatgttcggacagaagaagt 
iolW T46D S47V R48N -F tcacttcttctgtattaacatccatgattttgctgatttgatatt 
iolW T46D S47V R48N -R aatatcaaatcagcaaaatcatggatgttaatacagaagaagtga 
iolW R48D –F ccgtttcacttcttctgtatctgatgtcatgattttgctgattt 
iolW R48D –R aaatcagcaaaatcatgacatcagatacagaagaagtgaaacgg 
iolG-XhoI-R tttctcgagttgaactgttgtaaa 
iolW-XhoI-R ccgctcgaggtgctccagcataatggttc 
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For the chimeric mutagenesis, the regions relevant to the ‘GxGxxG’ motif model 
were selected to be replaced from one enzyme to another. For example, according to the 
possible electronic bonds simulated in Swiss-PDB viewer (Swiss Institute of Bioinformatics), 
the N-terminal region of IolG up to the 57
th
 residue and the C-terminal region of IolW from 
the 63
rd
 residue and after were selected and joined to produce the mutant derivative 
IolGW5663 (Fig. 4-2). The IolGW5663 cassette was made of two PCR fragments, which 
were amplified from the chromosomal DNA of strain 168 with primer pair of iolG-NdeI-
F/iolG56-R and iolW63(G)-F/iolW-XhoI-R, respectively (Table 4-2). These two PCR 
fragments were ligated to be IolGW5663 by recombinant PCR with the iolG-NdeI-F/iolW-
XhoI-R primer pair (Table 4-2). Similarly, the N-terminal region of IolX up to the 39
th
 
residue amplified with iolX-NdeI-F/iolX39-R primers (Table 4-2) and the C-terminal region 
of IolW from the 49
th
 residue and after with iolW49-F/iolW-XhoI-R (Table 4-2) were ligated 
to be the IolXW3949 cassette with iolX-NdeI-F/iolW-XhoI-R (Table 4-2). The N-terminal 
region of IolX up to the 56
th
 residue amplified with iolX-NdeI-F/iolX56-R (Table 4-2) and 
the C-terminal region of IolW from the 63
rd
 residue and after with iolW63(X)-F/iolW-XhoI-R 
(Table 4-2) were to be the IolXW5663 cassette with iolX-NdeI-F/ iolW-XhoI-R (Table 4-2). 
Finally, the N-terminal region of IolX up to the 57
th
 residue was amplified with iolX-NdeI-
F/iolX57-R (Table 4-2) and the C-terminal region of IolW from the 54
th
 residue and after 
with iolW64(X)-F/iolW-XhoI-R (Table 4-2) were to be the IolXW5764 cassette with the 
iolX-NdeI-F/iolW-XhoI-R (Table 4-2). 
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Fig. 4-2. The construction of chimeric mutants. (a) Schematic linear modeling of the chimeric mutant 
construction. The predicted α-helixes and β-sheets are aligned and schematically shown on to the liner 
models of IolG (blue), IolX (yellow), and IolW (green). (b) Three dimensional structure of mutants 
compared with IolG, IolX, IolW, and the four chimeric mutnats by Swiss-PDB viewer. The mutant 
models were provided from Molecular Bioinformatics Center (National Chiao Tung University) 
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For the site-directed mutagenesis, the cofactor active sites in IolG and IolW were 
selected as the mutation target sites in this study (Fig. 4-1). The cofactor binding sites contain 
the ‘GxGxxG’ motif for the cofactor binding. The cofactor active sites were predicted 
between the end of the β2 and in front of α2 of the enzymes and located at 18~19 amino acid 
residues downstream of the ‘GxGxxG’ motif. To change the cofactor specificity of IolG, the 
35
th
 aspartate and 38
th
 glutamine residues of IolG were changed to arginine. For IolW, the 
46
th
 threonine, the 47
th
 serine, and the 48
th
 arginine residues were replaced to aspartate, 
proline/valine, and leucine/asparagine/aspartate, respectively. In this way, eight mutants, 
including IolG-D35R, IolG-Q38R, IolW-T46D, IolW-T46D/S47P, IolW-T46D/S47P/R48L, 
IolW-T46D/S47V, IolW-T46D/S47V/R48N and IolW-R48D were constructed. To construct 
each of the IolG based site-directed mutants, two PCR fragments were amplified from the 
chromosomal DNA of strain 168 with respective two specific primer pairs; for IolG-D35R, 
iolG-NdeI-F/iolG D35R-R and iolG D35R-F/iolG-XhoI, and for IolG-Q38R, iolG-NdeI-
F/iolG Q38R-R and iolG Q38R-F/iolG-XhoI-R (Table 4-2). These respective two fragments 
were ligated to be the IolG-D35R and IolG-Q38R cassettes by recombinant PCR with the 
iolG-NdeI-F/iolG-XhoI-R primer pairs (Table 4-2). Likewise, the IolW based site-directed 
mutants were constructed by PCR using the specific primer pairs as follows; for IolW-T46D, 
iolW-NdeI-F/iolW T46D-R and iolW T46D-F/iolW-XhoI-R (Table 4-2), for IolW-T46D/S47P, 
iolW-NdeI-F/iolW T46D S47P-R and iolW T46D S47P-F/iolW-XhoI-R (Table 4-2), for 
IolW-T46D/S47P/R48L, iolW-NdeI-F/iolW T46D S47P R48L-R and iolW T46D S47P 
R48L-F/iolW-XhoI-R (Table 4-2), for IolW-T46D/S47V, iolW-NdeI-F/iolW T46D S47V-R 
and iolW T46D S47V-F/iolW-XhoI-R (Table 4-2), for IolW-T46D/S47V/R48N, iolW-NdeI-
F/iolW T46D S47V R48N-R and iolW T46D S47V R48N-F/iolW-XhoI-R (Table 4-2), and 
for IolW-R48D, iolW-NdeI-F/iolW R48D-R and iolW R48D-F/iolW-XhoI-R (Table 4-2). 
These respective two PCR fragments pairs were ligated via recombinant PCR with the iolW-
NdeI-F/iolW-XhoI-R (Table 4-2). 
 
Plasmid construction 
To produce His6-tagged mutant derivatives of inositol dehydrogenases in E. coli, the 
recombinant PCR fragments of the respective mutant cassettes were cloned into pET-30a. 
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The respective mutant cassettes were amplified and inserted into the TA-cloning site of 
pMD20, which was introduced into E. coli DH5α using a TA-cloning kit (Takara Bio). The 
pMD20-derivative plasmid was digested with NdeI and XhoI, and the insert DNA was 
isolated and ligated to the arms of pET-30a, which was previously linearized with the same 
restriction enzymes. The recombinant plasmid was used to transform DH5α to become 
kanamycin resistant, and correct construction of the plasmid designated as ‘pET-mutants’ 
were confirmed by sequencing. Each mutant plasmids was introduced into E. coli BL21(DE3) 
for production of His6-tagged mutant derivatives. The constructed mutant plasmids were 
listed in Table 4-3. Additionally, to produce His6-tagged IolG in E. coli, the plasmid pET-iolG 
was constructed. Briefly, a PCR fragment corresponding to the coding region of iolG was 
amplified from DNA of strain 168 with the iolG-NcoI-F/iolG-XhoI-R primer pair (Table 4-2) 
to generate NcoI and XhoI sites at the head and tail, respectively. The PCR product was 
digested with NcoI and XhoI, and the insert DNA was isolated and ligated to the arms of pET-
28b(+), which was previously linearized with the same restriction enzymes. The recombinant 
plasmid was used to transform DH5α to become kanamycin resistant, and correct 
construction of the plasmid designated as pET-iolG was confirmed by sequencing. pET-iolG 
was introduced into E. coli BL21(DE3) for production of His6-tagged IolG. And the plasmids 
pET-iolW and pET-iolX were previously constructed to produce His6-tagged IolW and IolX 
in E. coli, respectively (Morinaga et al., 2010a). 
 
Enzyme production, purification, and assays. 
E. coli BL21(DE3) cells carrying each recombinant DNA were inoculated into LB 
medium containing kanamycin and allowed to grow at 37°C with shaking. At an OD660 of 
0.35, 1 mM IPTG was added into the medium to induce production of the His6-tagged 
enzymes, and the culture was further incubated for 2 h at 37°C with shaking. Then, the cells 
were harvested and disrupted by brief sonication. From the cell lysate, His6-tagged enzymes 
were purified by Ni-Co affinity chromatography according to supplier’s instructions (Takara 
Bio).  
The purified His6-tag fusion enzymes were assayed spectrophotometrically for 
inositol dehydrogenase activity. Briefly, 50 μg of each purified enzyme was combined in 1 ml 
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of reaction mixture containing 100 mM Tris-HCl (pH 7.5), 500 μM of cofactor (NAD+ or 
NADP
+
), and 20 mM of substrate (SI or MI). The enzyme activity was measured by 
following the increase in absorbance at 340 nm associated with the reduction of NAD(P)
+
 at 
37°C for 5 min (Ramaley et al., 1979).  
 
Results and Discussion 
The enzymatic activity of chimeric mutagenesis mutants 
In the chimeric mutagenesis, all the four mutants, including IolXW3949, IolXW5764, 
IolXW5663 and IolGW5663, were produced and purified successfully. Each of IolG, IolW 
and IolX was also purified to exhibit the inositol dehydrogenase activity with substrate and 
cofactor specificities as reported previously. However, none of the chimeric mutants showed 
any detectable activity on MI/SI in the presence of NAD
+
/NADP
+
 (Table 4-3). The chimeric 
mutations were carefully designed not to change the overall structure of the enzymes as 
shown for the three dimensional models in Fig. 4-2. Nevertheless, the results indicated that 
the mutagenesis abolished their enzymatic functions. Therefore, the author changed his 
strategy to perform the site-directed mutagenesis to replace selected amino acid residues 
within the cofactor active sites. 
 
The enzyme activity of site-directed mutagenesis mutants 
In site-directed mutagenesis, the author produced eight mutants successfully, named 
IolG-D35R, IolG-Q38R, IolW-T46D, IolW-T46D/S47P, IolW-T46D/S47P/R48L, IolW-
T46D/S47V, IolW-T46D/S47V/R48N, and IolW-R48D. As shown at Table 4-3, there found 
only two mutants of IolX exhibited the enzymatic activity, and none of IolW derivatives 
showed activity. The results indicate that the mutated residues in IolW are indispensable for 
enzymatic function, and some of them might be involved in cofactor specificity. 
In spite of the mutagenesis within the cofactor active site, IolG-D35R still required 
NAD
+
 but its activity was lowered significantly. The 35
th
 aspartate residue in IolG, positioned 
between β2 and α2, was speculated to be the key residue to coordinate the dehydrogenation 
reaction involving the cofactor NAD
+
. However, it could be replaced to arginine from the 
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original aspartate. The results suggested that the 35
th
 aspartate residue in IolG might not be 
the major determinant of cofactor specificity but required for the enzymatic efficiency. On the 
other hand, IolG-Q38R exhibited enhanced activity with NAD
+
, and surprisingly it was able 
to utilize NADP
+
 with a very weak activity. The 38
th
 glutamine residue was replaced to 
arginine, which might mimic the 48
th
 arginine of IolW located in the beginning position of α2. 
These results suggested that the amino acid residues contained in the cofactor active 
site of IolG could be involved in cofactor specificity. Only recently, a similar study was 
reported by Zheng and the colleagues (Zheng et al., 2013). They were successful in switching 
IolG cofactor specificity from NAD
+
 to NADP
+
. They focused various amino acid residues 
not only 35
th
 aspartate, which is the key residue acting with NAD
+
, but also the 12
th
 alanine, 
the 14
th
 glycine, the 36
th
 valine, and the 40
th
 alanine residues, which are thought to coordinate 
the cofactor positioning, to stand for the last glycine residue of ‘GxGxxG’ motif, and to make 
a “pocket” for phosphate binding, respectively. In their results indicated that changing the 
35
th
 aspartate residue to serine (D35S) enabled the weaker enzyme activity depending 
NADP
+
. The additional double mutation changing the 12
th
 alanine residue to lysine (A12K) 
and D35S resulted only in a similar property of the single mutation of D35S. On the other 
hand, additional mutations changing the 36
th
 valine residue to arginine (V36R) and the 40
th
 
alanine residue to lysine (A40K) enhanced the NADP
+
 dependency of the alter the enzymes. 
Therefore, they concluded that the 35
th
 aspartate residue together with the 36
th
 valine residue 
and the 40
th
 alanine residue could be the determinants of cofactor specificity of IolG. As 
described above, however, the author speculated that the 35
th
 aspartate residue in IolG might 
not be the major determinant of cofactor specificity but required for the enzymatic efficiency. 
The difference in these two studies is the amino acid selected for substitution of the 35
th
 
aspartate residue, serine or arginine. Since serine or arginine was supposed to be a 
determinant for NADP
+
, the author chose arginine, which was a wrong choice to change the 
cofactor specificity. 
On the other hand, this study failed to produce IolW derivatives with detectable 
activity, and important residues for cofactor specificity of IolW remained to be clarified. 
Obviously, further investigation with site-directed mutagenesis would be conducted to reveal 
the relationship between structure and function of IolW in the near future. 
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Table 4-3. Inositol dehydrogenase activity of purified mutant enzymes 
Enzyme Substrate Cofactor Activity (nmol min
−1 
mg
−1
) 
IolG MI 
NAD
+
 47.0 
NADP
+
 ND* 
IolW SI 
NAD
+
 ND* 
NADP
+
 42.2 
IolX SI 
NAD
+
 91.6 
NADP
+
 ND* 
IolXW3949 SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolXW5663 SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolXW5764 SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolGW5663 SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolG-D35R MI 
NAD
+
 0.43 
NADP
+
 ND* 
IolG-E38R MI 
NAD
+
 97.7 
NADP
+
 0.13 
IolW-T46D SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolW-T46D/S47P SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolW-T46D/S47P/R48L SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolW-T46D/S47V SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolW-T46D/S47V/R48N SI 
NAD
+
 ND* 
NADP
+
 ND* 
IolW-R48D SI 
NAD
+
 ND* 
NADP
+
 ND* 
ND*: Not detected ( <0.01) 
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Chapter 5 
General Discussion 
 
In B. subtilis, MI is used as the sole carbon source through the multiple enzymatic 
functions mostly encoded by iolABCDEFGHI operon as described in Chapter 1 (Yoshida et 
al., 2008). MI once appears in the cell is dehydrogenated by the reaction catalyzed by IolG of 
the major NAD
+
-dependent MI dehydrogenase, and further degraded through the stepwise 
reactions catalyzed by the Iol enzymes to yield the two common metabolic intermediates, 
dihydroxyacetone phosphate and acetyl CoA (Yoshida et al., 2008). In addition, B. subtilis is 
capable of degrading at least the other two inositol stereoisomers, namely DCI and SI. Both 
are processed to be SIS and further degraded similarly as MI. DCI is dehydrogenated by IolG 
as well and isomerized by IolI to be SIS (Yoshida et al., 2006). On the other hand, first 
degradation of SI depends on IolX encoding the NAD
+
-dependent SI dehydrogenase 
(Morinaga et al., 2010a), while IolW (Morinaga et al., 2010a) are capable of reducing SIS 
into SI with oxidation of NADPH. IolG, IolX, and IolW, have been regarded as the major 
three inositol dehydrogenases, and all of them belong to the Gfo/Idh/MocA protein family 
together with the other paralogous gene products NtdC, YfiI, YrbE, YteT and IolU (Kang et 
al., 2017). NtdC is NAD
+
-dependent glucose-6-phosphate dehydrogenase (Vetter et al., 2013), 
but the roles of YfiI, YrbE, YteT, and IolU were unknown. Only recently, the role of IolU was 
identified as a functional paralog of IolW, and thus there are four inositol dehydrogenases in 
B. subtilis. 
It is known that expression of iolG is under the control of the repressor encoded by 
iolR together with the rest of iolABCDEFGHI operon (Yoshida et al., 1997). Transcription of 
iolW was reportedly constitutive (Morinaga et al., 2010a) but recently was shown to be 
elevated under certain stressful conditions under the regulation of sigma B (Höper et al., 
2005). So far nothing is known about regulation of iolU, but has been shown to be transcribed 
generally at low levels in an approximately constitutive manner (Nicolas et al., 2012). 
Transcription of iolX is induced in the presence of SI (Morinaga et al., 2010a), however its 
underlying mechanism remained to be investigated. Thus as described in Chapter 2, the 
author conducted an intensive investigation for transcriptional regulation mechanism of iolX. 
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YisR and DegA were the candidates for regulators of iolX; the former is a member of the 
AraC/XylS family including mainly positive transcription regulators (Morohoshi et al., 1993), 
and the latter a member of the LacI family of negative transcription regulators (Fukami-
Kobayashi, 2003) with the typical helix-turn-helix motif, characteristic of a DNA-binding 
domain (Weickert & Adhya, 1992). YisR turned out to play no role in iolX regulation, 
whereas DegA controlled IolX expression negatively as a repressor, which binds to two 
different sites within the iolX promoter region; one is from +4 to +30 and the other from +68 
to +88 (Fig. 2-5). As is often the case with the LacI family members bound to DNA with 
specific palindromic sequences (Fukami-Kobayashi, 2003), the two DegA-binding sites were 
found to share a relatively conserved sequence AGAAARCGCTTKCK (where R = A or G 
and K = G or T), with the potential perfect palindrome AGAAAGCGCTTTCT. Within the B. 
subtilis genome, 22 sites were found with a sequence similar to the conserved consensus 
sequence, and seven of them are close to independent promoter regions. This finding implies 
the possibility that DegA might be involved in regulating of the six promoters for the genes as 
follows: glpT, ycsA, aco, yrbE, menA, and bglS. Our future course will focus on determining 
the mechanisms of transcriptional regulation of these genes and their involvement in SI 
metabolism. 
The author confirmed that DNA-binding activity of DegA in B. subtilis was not 
released in the presence of MI, SI, or SIS. Nevertheless, only recently a homolog of DegA in 
Geobacillus kaustophilus was found to function as a transcriptional repressor for the two iol 
operon of this microorganism (Yoshida et al. unpublished observation). It bound to the DNA 
with a conserved sequence of GPAAGCGCTTXCW (where P = A or T and X = G or C or T 
and W = T or C), and its DNA binding in vitro was antagonized in the presence of MI 
(Yoshida et al. unpublished observation). DegA in B. subtilis and its homolog in G. 
kaustophilus share a significant homology [identities = 169/332 (51%), similarity = 238/332 
(72%)], and their recognition consensus sequences resemble to each other. The helix-turn-
helix motif of LacI family is located within the N-terminal part in each of them, where their 
amino acid sequences are conserved intensively so that they might recognize the similar DNA 
sequences. On the other hand, their C-terminal parts are relatively less conserved, implying 
that an unidentified inducer compound for DegA in B. subtilis might interact with the C-
terminal region. 
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 In Chapter 3, the author identified IolU as an NADP
+
-dependent SI dehydrogenase in 
addition to IolW. IolU turned out to be less efficient in the enzyme activity and only catalyzes 
the reaction to reduce SIS into SI. As mentioned above, transcriptional expression of iolU is 
maintained at low levels (Nicolas et al., 2012), and it only convert SIS to SI in vitro, 
indicating it functions to consume NADPH. Therefore, IolU might not be required for 
inositol metabolism but primarily functions as NADPH-dependent oxidoreductase under 
physiological conditions. Examining IolU for its substrate specificity beyond SIS may 
provide a more holistic picture of its physiological role. In addition, transcriptional regulation 
of iolU remains to be investigated. It was shown to be transcribed generally at low levels in 
an approximately constitutive manner (Nicolas et al., 2012). Therefore, finding the conditions 
to induce iolU would also be one of the ways to identify its physiological function. 
Switching cofactor specificity of enzymes is one of the most common approaches to 
elucidate the relation between their structure and function, as described for the researches on 
arabinitol dehydrogenase (Bae et al., 2010), formate dehydrogenase (Hoelsch et al., 2013), 
xylitol dehydrogenase (Watanabe et al., 2005), ketol-acid reductoisomerase (Bastian et al., 
2011), and alcohol dehydrogenase (Bastian et al., 2011). In Chapter 4, the author tried to 
switch cofactor specificity of the three major inositol dehydrogenases, IolG, IolX, and IolW. 
The author took two ways to mutagenize the inositol dehydrogenases; the one was chimeric 
mutagenesis, and the other site-directed one. The chimeric mutagenesis failed to produce 
mutants with detectable activities, while the site-selected mutagenesis resulted in some 
findings as follows. One of the mutants of IolG, IolG-D35R, exhibited lowered activity acting 
on MI with reduction of NAD
+
, while another mutant IolG-Q38R elevated the MI 
dehydrogenase activity with NAD
+
 and was weak but still reactive with NADP
+
. The 
aspartate and arginine/serine residues located at 18-19 downstream from ‘GxGxxG’ motif are 
reported as the key residue to activate cofactors (Lesk, 1995). The results that IolG-D35R 
was decreased its activity indicated that the 35
th
 aspartate residue could be the key residue. In 
addition, the substituted arginine residue of IolG-Q38R might have made a phosphate pocket 
to increase NADP
+
 binding, but the effect was not so significant. Only recently, Zheng and 
the colleagues reported their studies to switch the cofactor specificity of IolG (Zheng et al., 
2013). They replaced not only the 35
th
 aspartate residue to serine (D35S) but also the 12
th
 
alanine residue to lysine (A12K), the 14
th
 glycine residue to alanine (G14A), the 36
th
 valine 
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residue to arginine (V36R), and the 40
th
 alanine to lysine (A40K) (Zheng et al., 2013). D35S 
showed some weak activity with NADP
+
. And either the mutations of V36R or A40K in 
additional to D35S was increased NADP
+
-dependency (Zheng et al., 2013). They concluded 
that the 35
th
 aspartate residue together with the 36
th
 valine residue and the 40
th
 alanine residue 
could determine cofactor specificity of IolG. However, the author found that substitution of 
the 35
th
 aspartate residue to arginine did not change the cofactor specificity. Because arginine 
or serine could be involved in preference for NADP
+
, the choice of the author, arginine, could 
be wrong to change the cofactor. On the other hand, the author was not able to produce active 
IolW derivatives, and no other studies to determine cofactor specificity of IolW have been 
reported so far. It would be worthwhile to conduct further site-directed mutagenesis on IolW 
to elucidate the relationship between its structure and function. 
During the studies described in this thesis, the author worked on elucidation of 
transcriptional regulation of iolX encoding NAD
+
-dependent SI dehydrogenase, identification 
of the additional NADP
+
-dependent SI dehydrogenase IolU, and tried to switch cofactor 
specificity of the three major inositol dehydrogenases. The results of this study are highly 
beneficial in the future to elucidate the function of unknown genes in not only B. subtilis but 
also various bacteria, since the rapid development in genome sequencing has facilitated to 
determine the entire genomic information. A large number of genes encoding inositol 
dehydrogenase belonging to the Gfo/Idh/MocA protein family has already been identified in 
many bacterial genomes. The abundance of such genes might imply the possible significance 
in metabolism of inositol and its related compound in bacteria. Obviously, in many of 
eukaryotes, inositol and its derivatives play important roles in structural and regulatory 
aspects to maintain, proliferate, and develop the cell. To elucidate the overall picture of 
inositol metabolism in prokaryotes would lead to insight into the origin of the special 
function of inositol acquired by eukaryotes. 
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Chapter 6 
Conclusion 
 
Strains of B. subtilis utilize some of stereoisomers inositol, including MI, DCI, and 
SI, as the sole carbon source for cell growth depending on the specific inositol metabolic 
pathway. The inositol metabolic pathway is mainly due to enzymatic functions encoded by 
iolABCDEFGHIJ operon. The first reaction of inositol metabolism, MI and DCI was 
degraded by IolG to SIS and 1KDCI, respectively, and 1KDCI was converted to SIS by IolI. 
SIS was further degraded by the other enzymes encoded by the iol operon to yield the two 
common metabolic intermediates, dihydroxyacetone phosphate and acetyl CoA. Additionally, 
two SI dehydrogenases, IolW and IolX, are related first reaction of SI degradation to covert 
this compound into SIS, which is degraded further similarly to MI and DCI.  
Production of IolG is regulated by IolR to be induced in the presence of MI, and 
IolW is constitutively produced and induced by stress-responsive sigma-B. On the other hand, 
previously IolX was shown to be induced at least in response to SI, but the underlying 
mechanism was to be clarified. Therefore, the author investigated transcriptional regulation of 
iolX. The two genes, yisR and degA, located of just upstream of iolX, belong to the 
AraC/XylS and the LacI families of transcriptional regulators, respectively. Even in the 
absence of functional iolX, the presence of SI or MI in the growth medium induces the 
transcription of iolX through an unknown mechanism. Immediately upstream of iolX, there is 
an operon encoding two genes, yisR and degA, each of which could encode a transcriptional 
regulator. The inactivation analysis of yisR and degA was performed to reveal that degA 
likely encodes a repressor of iolX transcription. The coding sequence of the degA was 
expressed in E. coli as a His-tagged fusion protein that bound specifically in vitro to two sites 
within the iolX promoter region. Genetic evidences allowed the author to speculate that SI 
and/or MI might possibly be the intracellular inducer antagonizing DNA binding of DegA, 
however the in vitro experiments failed to support this possibility. 
 B. subtilis genes iolG, iolW, iolX, ntdC, yfiI, yrbE, yteT, and yulF belong to the 
Gfo/Idh/MocA family. The functions of iolG, iolW, iolX, and ntdC were demonstrated 
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experimentally. However, none of the others is known. It was previously reported that the B. 
subtilis cell factory simultaneously overexpressing iolG and iolW was enabled to achieve 
bioconversion of MI into SI. YulF shares a significant similarity with IolW, but its 
transcriptional abundance did not correlate to that of iol genes. However, overexpression of 
yulF instead of iolW in the B. subtilis cell factory resulted in conversion of MI into SI, 
suggesting its similar function to iolW. The recombinant His6-tagged YulF was produced in E. 
coli to convert SIS into SI depending on NADPH in vitro. The author has thus identified yulF 
encoding an additional NADP
+
-dependent SI dehydrogenase to rename it as iolU. 
 Members belonging to the Gfo/Idh/MocA family proteins, including IolG, IolX and 
IolW, share a consensus NAD
+
/NADP
+
 specific binding region with the ‘GxGxxG’ motif. In 
addition, an aspartate residue for NAD
+
- and an arginine/serine residue for NADP
+
-
dependent enzymes were detected for its key amino acid in 18-19 downstream of ‘GxGxxG’ 
motif. The author made mutant enzymes by chimeric mutagenesis and site-directed 
mutagenesis in trial to switch the cofactor specificities of IolG, IolX and IolW; the former 
two are NAD
+
-dependent and the last latter NADP
+
-dependent. In chimeric mutagenesis, the 
author replaced the N-terminal regions containing the ‘GxGxxG’ motif of IolW with those of 
IolG and IolX, but failed to produce any mutant with detectable activity. Therefore, the author 
changed the strategy to conduct the site-directed mutagenesis to replace some of key amino 
acid residues. One of the mutants of IolG, IolG-D35R, exhibited lowered activity acting on 
MI with reduction of NAD
+
, while another mutant IolG-Q38R elevated the MI 
dehydrogenase reactivity with NAD
+
 and was weak but still reactive with NADP
+
. The 35
th
 
aspartate residue could be one of the key residues, and the arginine residue of IolG-Q38R 
might have made a phosphate pocket to increase NADP
+
 binding but its effect was limited. 
On the other hand, none of the IolW derivatives exhibited a detectable activity, and no other 
studies to determine cofactor specificity of IolW have been reported so far. It would be 
worthwhile to conduct further site-directed mutagenesis on IolW to elucidate the relationship 
between its structure and function. 
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私の日本での生活の立ち上げを助けてくださった日本のホストファミリー青井家のお父さんと
お母さんやその娘さんと孫たち(前田家の皆さん)、一緒に生活したホストブラザー、MitchとRyan、
私の結婚式にも参加いただいた木谷さんとマキさんにも感謝申します。そして、神戸韓国歌コンテス
トの縁で仲良くなった中村さん夫婦、セリカ姉さん、サヤカ姉さん、エムさん夫婦だけではなく、私
の韓国語教室の生徒だった橋場さん、柳さん、礼子さん、チエ姉さん、トモミ姉さんにも感謝します。
さらに、日本で出会った韓国人の皆さん、イム兄さん夫婦、マ兄さん夫婦、ヒョクォン兄さん、ジェ
ウォン、ハンギョル、その他にも色々、本当に5年間辛いときも楽しいときも、いつも一緒にしてく
れて有難うございました。 
韓国で私の卒業を待っていた友達、チャンホ、ギュミン、ジンフィ、ハンジュン、デギュ、ヨ
ンジュン、ジョンヨップ、ヨンス、チャンヨンにも、そして数が多すぎてここには到底書ききれない
韓国国際大学の後輩達や釜山大学医学専門大学院医科学科の先輩･後輩達、今までの私に助けてくだ
さったジョン先生、アン先生、チェ先生、ジョン先生、ソ先生、シン先生、金先生にも感謝申します。 
最後にいつも私の味方になってくださる父と母、いつも一人生活を心配してくださる義父と義
母、双子を産んで2倍疲れている姉と義兄、間もなく結婚して一つの家庭を作る義妹と相婿、熱心に
勉強中の義弟、そして私が一番愛する妻ボミンと娘リハに愛と感謝の気持ちを伝えながら、今まで私
が来たこの道に光で明るくしてくださったすべての方々にこの論文を捧げます。 
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